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1.1 Multiple Sclerosis 
Multiple Sclerosis (MS) is a common neurological condition in which the body’s own 
immune system attacks cells within the brain and spinal cord. A broad range of signs 
and symptoms are associated with MS and often linked to the location of damage. As 
the disease progresses, an accumulation of disability builds placing a substantial 
burden on individuals, families and society. There is presently no cure for MS; 
however, several therapies exist that can modify the disease course as well targeting 
specific symptoms. Therefore, a key priority for intervention and rehabilitation is to 
offer personalised treatment to every person with MS to minimise disease impact and 
enhance quality of life.  
1.2 Systematic Review 
Cognitive impairment affects a significant portion of people with MS and is associated 
with worse prognosis and functional difficulties. It has become increasing recognised 
that cerebellar signs and cognitive dysfunction often occur in parallel in Relapsing-
Remitting MS (RR-MS). Individuals who show physical signs of cerebellar involvement 
such as tremor and poor coordination experience greater disease-related impairment 
and poorer rehabilitation outcomes. Consequently, there is growing interest in the 
relationship between the cerebellum and cognition in MS. 
A Systematic Review was conducted to investigate the contribution of the cerebellum 
to cognitive performance and other related variables in RR-MS. The aim was to 
provide a more objective appraisal of the literature and consider the proposed 
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existence of a distinct cognitive profile for RR-MS patients with cerebellar damage (RR-
MSc).  
Online literature databases were systematically reviewed for relevant articles. All 
articles that utilised any neuropsychological outcome measure to examine the 
relationship between cognition and the cerebellum and met inclusion criteria were 
included. Data on participants, study characteristics and key findings were extracted 
and summarised. Study methodology was assessed using a quality rating tool.  
A total of 14 studies were included encompassing data from 433 patients. From the 
demographic information available, case participants were predominately female 
(73%), had a x ̅age of 36.8, disease duration ranged from 2 – 12.1 years, had at least 
secondary school education, with an Expanded Disability Severity Scale (EDSS) x ̅score 
of 2.0, indicating minimal disability. The most commonly assessed domains of 
cognition were information processing speed (IPS), verbal memory and verbal fluency. 
The Symbol Digit Modalities Test (SDMT), Paced Auditory Serial Addiction Task 
(PASAT), both measures of information processing speed; Controlled Oral Word 
Association Test (COWAT), verbal fluency; and Nine-Hole Peg Test (NHPT), upper limb 
motor function, were the most frequently used outcome measures. The 
methodological quality of the studies included was rated as fair to strong.  
Several research highlights were considered. The most common and severe cognitive 
impairments were associated with IPS followed by executive dysfunction and reduced 
verbal fluency. There was minimal evidence of verbal or visual memory deficits. There 
was preliminary support for a differential cognitive profile between RR-MS patients 
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with cerebellar signs (RR-MSc) and those without cerebellar signs (RR-MSnc). The 
cognitive profile of RR-MSc was associated with further reduced IPS, and more 
executive dysfunction, however more research was required to substantiate the 
finding. Cerebellar signs were strongly related to poor performance on motor function 
tasks. Evidence suggested that the cerebellum does not significantly contribute to 
fatigue or mood difficulties. 
The validity of findings was supported by previous reviews and clinical data from 
acquired cerebellar lesions. The findings were significant due to an improved 
characterisation of MS heterogeneity, which has implications for an improved 
understanding of mechanisms leading to deficits and development of tailored 
interventions. The field would benefit from an increased number of high quality 
studies, addressing methodological heterogeneity through stringent inclusion criteria 
and longer periods of observation to ascertain prognosis of cognitive impairment in 
RR-MS. 
The systematic review concluded that there is substantial evidence to support that the 
cerebellum contributes to cognitive performance, especially IPS, and motor function. 
The intricacies of cerebellar-related impairment remain unknown. A common 
theoretical explanation of the increased cognitive impairment with RR-MSc was that 
disruption to salient connections or ‘loops’ between cortical regions and the 
cerebellum might lead to costly inefficiencies. Further research was warranted to 
substantiate this theory.  
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1.3 Empirical Study 
The presence of cerebellar signs and cognitive impairment are associated with poor 
prognosis. As such, it is vital that research efforts focus on developing a clearer 
measurement of the interrelation of cerebellar cognitive impairment.  
The cerebellum forms part of salient cortico-cerebellar loops, which are responsible 
for a range of functions. It has been proposed that the cerebellum contributes to 
cognition and motor control through the creation and storage of automated 
subroutines, enabling precise execution of tasks without the need of feedback or 
conscious awareness. This results in an increase in task efficiency by acting as a 
‘shortcut’ and frees cortical regions to engage in other tasks. Conversely, cerebellar 
dysfunction caused by MS pathology reduces efficiency and optimal performance.  
Motor planning is the ability to conceive, plan and execute coordinated motor 
responses. Optimal performance is likely to be dependent on cerebellum integrity and 
therefore serves as a useful indicator of cerebellar function. Accordingly, inefficient 
motor planning will be associated with cognitive decline, particularly IPS, as the 
cerebellum mediates both. The recruitment of RR-MSc and comparing performance 
on motor planning and cognitive tasks with RR-MSnc offers an opportunity to further 
elucidate mechanisms. 
To calibrate motor planning, the Grooved Peg Test (GPT) - NHPT difference was used 
to compute a Motor Planning Index (MPI), with the NHPT serving as a control for 
sensorimotor impairment. 
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Therefore, the objective of the study was to investigate the longitudinal relation of 
cognition to cerebellar function in RR-MS, and how changes relate to motor planning 
and function. The following hypotheses were identified: 
1. The baseline cognitive profile of patients with RR-MSc compared with RR-MSnc 
and HC will be maintained at 1-year follow-up.  
2. The performance of patients with RR-MSc on cognitive and motor planning 
tasks will decline over a 1-year period compared to patients with RR-MSnc and 
HC, who in turn, will remain stable. 
3. Changes in motor planning will be related to changes in information processing 
speed (IPS) as the cerebellum mediates both. 
The study was an extension of a cross-sectional investigation of cognition and motor 
planning. Participants were recruited from Neurology clinics and assigned to three 
groups: RR-MSc, RR-MSnc and healthy controls (HC) using a validated self-report 
cerebellar symptom questionnaire (Tremor and Coordination Scale, TACS). 
Participants completed a test battery featuring the Brief International Cognitive 
Assessment for Multiple Sclerosis (BICAMS), Word List Generation (WLG), Paced 
Auditory Serial Addition Test (PASAT), Test of Premorbid Function (TOPF), NHPT and 
GPT. Additional questionnaires included the Fatigue Severity Scale (FSS), Hospital 
Anxiety and Depression Scale (HADS) and a measure of disability, Expanded Disability 
Severity Scale (EDSS). The procedure involved participants repeating the test battery 
with the additional measures of subjective motor function (ABILHAND) and visual 
acuity (Snellen Pocket Eye Test).  
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A total of 11 RR-MSc (5 males, x ̅age: 41, x ̅IQ: 100.9), 17 RR-MSnc (2 males, x ̅age: 41, 
x ̅IQ: 106.7) and 9 HC (2 males, x ̅age: 37.8, x ̅IQ: 107.0) were assessed at baseline and 
12 months. No participants were excluded from the study. The drop-out rates were as 
follows: 3 RR-MSc, 4 RR-MSnc and 21 HC. Reasons for drop out included: declined for 
personal reasons (10), unable to complete in recruitment window (12) and unable to 
contact (3). 
The analysis of the results found no significant demographic differences between the 
groups. Interestingly, there was a significant interaction for EDSS scores indicating the 
rate of disability grew progressively worse for RR-MSc compared to RR-MSnc (F(2,34) 
= 6.49, p = .017). A mixed model ANOVA was used to explore the main effect of group, 
time and interaction for each of the cognitive and motor measures. There was no 
significant interaction effect for any test. However, analysis revealed consistent 
significant group separation on the CVLT-II (F(2,34) = 8.52, p = .001), SDMT (F(2,34) = 
6.12, p = .005), NHPT (F(2,34) = 29.11, p <.001), GPT (F(2,34) = 11.74, p <.001) and MPI 
(F(2,34) = 14.19, p <.001) but not for the BVMT-R (F(2,34) = .387, p = .682). There was 
a significant effect of time for the BVMT-R (F(1,34) = 4.74, p = .037) and the CVLT-II 
(F(1,34) = 18.83, p <.001). Finally, there was a significant moderate negative 
correlation between the MPI and IPS. The SDMT was more strongly correlated with 
motor planning (r(27)= -.611, p <.001) than the PASAT-3 (r(27)= -.5, p =.002). There 
was a weak positive correlation between ABILHAND and NPT (r(27)= .39, p =.017) and 
the GPT (r(27)= .35, p =.033) 
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In relation to the hypotheses, it was highlighted that the RR-MSc group were 
significantly outperformed by RR-MSnc and HC groups on all cognitive measures aside 
from the BVMT-R. There were no significant differences between RR-MSnc and HC 
groups. The RR-MSc group were characterised by greater impairment on tests of 
cognition, motor function and motor planning. Contrary to the second hypothesis, the 
magnitude of group differences remained stable for all groups. Lastly, evidence 
suggested that the MPI was able to capture the interrelation of cognitive cerebellar 
damage as indicated by the significant associations with measures of IPS, thus 
supporting the third hypothesis. 
Several limitations were noted. Firstly, patient heterogeneity may have masked true 
effects. The test battery could have benefited from additional tests for executive 
dysfunction. The MPI suffered from methodological concerns including the unequal 
sensorimotor components of the NHPT and GPT which were not accounted for. 
Results must be considered with caution given the high rate of attrition and the 
increased likelihood of type II error due to multiple statistical analysis. There was an 
implication that the study was underpowered to detect certain effects. 
It was concluded that RR-MSc may represent a distinct subtype characterised by 
greater impairment in several domains. These differences were maintained over a 
year. Furthermore, the findings provide theoretical support that the reduced 
performance of the RR-MSc group is thought to be related to a reduction in cerebellar 
function through the loss of subroutines which are considered important for 
efficiency. The MPI is potentially a promising tool to measure the interrelation of 
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cerebellar cognitive impairment. The next step is to validate the MPI with an MRI study 
exploring how it relates to cerebellar lesion load and atrophy. This would ensure that 
results do not merely reflect the influence of disease severity. 
1.4 Integration, Impact and Dissemination 
Integration 
- To aid integration a clear narrative revolving around the contribution of the 
cerebellum to cognition and how this related to motor planning was developed 
and expanded through each thesis component. The underlying intention was 
always to return the focus to improving the lives of those affected by MS. 
- There were several challenges encountered including the practicalities of 
adding a longitudinal component to a cross-sectional study and encountering 
issues with attrition. 
- Relevant clinical experience on placement, supervision and shared discussions 
with collaborators and service-user involvement were all useful in overcoming 
difficulties and integrating the thesis. 
Impact  
- The proposal that RR-MSc may warrant a distinct subtype has the potential to 
aid theoretical understanding and enable more tailored interventions for a 
group associated with poor rehabilitation outcomes. 
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- Prognostic information of RR-MSc provides greater insight for clinicians and an 
opportunity for more personalised information, feedback and education for 
patients and their support network. 
- The MPI represents a useful tool for the measurement of interrelation of 
cerebellar cognitive impairment. 
- The research aligns with grassroot campaigns such as the #ThinkHand 
movement which aims to draw attention to the importance of upper limb 
function in MS. 
- The personal impact of working with people with MS has provided greater 
insight into living with a chronic condition and knowledge to aid my career as 
a neuropsychologist.   
Dissemination  
- For the research to reach a diverse audience, the dissemination strategy 
focuses on a communication campaign across several channels. 
- Proposed dissemination routes include: 
• A plain English summary to research participants and associated 
clinicians. 
• Approaching national MS organisations, popular blogs (e.g. BartsMS 
Blog). 
• Submission of an abstract to European Committee for the Treatment 
and Research in Multiple Sclerosis (ECTRIMS) conference to target a 
global audience.  
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• The use of social media to promote the research, increase visibility and 
generate engagement. 
• Submission of systematic review and empirical study to a peer review 
journal e.g. Multiple Sclerosis and Related Disorders Journal or Multiple 
Sclerosis Journal. 
   
 
2. The Contribution of the Cerebellum to Cognitive 
Performance and Related Variables in Relapsing-
Remitting Multiple Sclerosis: A Systematic Review. 
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2.1 Abstract 
Cognitive impairment is a common and debilitating feature of Multiple Sclerosis (MS). 
An understanding of the factors that contribute to cognitive deficits remains a key 
area for research. Given cerebellar damage is associated with poorer disease-related 
outcomes, there is a considerable amount of interest in role of the cerebellum and the 
relationship to cognitive performance in MS. 
The objective was to conduct a systematic review of all studies published in English 
that measured the impact of cerebellar damage on cognition in Relapsing-Remitting 
MS (RR-MS), providing an overview of key findings and an objective evaluation of the 
content and methodological quality of studies included.  
Online literature databases (PubMed, Web of Science, Google Scholar and OVID) were 
systematically reviewed for relevant articles. All articles that utilised any 
neuropsychological measure in RR-MS to explore the relationship between cognition 
and the cerebellum and met inclusion criteria were included. Data on study 
characteristics and results were extracted and article quality was assessed.  
A total of 14 studies were included encompassing data from 433 MS patients. The 
overall quality of articles was either fair or strong according to a validated test of 
methodological quality. A review of key data revealed evidence for cerebellar 
involvement in information processing speed, executive functioning and motor 
functioning. There was little evidence for cerebellar involvement in other cognitive 
domains or relation to mood or fatigue symptoms. 
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There was substantial evidence to support that cerebellar damage adversely affected 
cognitive performance, particularly regarding information processing speed, although 
the intricacies of the cerebellar-related cognitive impairment remain elusive. The field 
would benefit from addressing methodological heterogeneity and increased 
prevalence of longitudinal studies to ascertain prognosis and interrelation of 
cerebellar cognitive impairment. 
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2.2 Introduction 
The prevalence of Multiple Sclerosis (MS) in the United Kingdom is increasing 
(Mackenzie, Morant, Bloomfield, MacDonald, & O’Riordan, 2014). The disease places 
a substantial burden on individuals, families and society, and as such there is a need 
for research efforts to focus on the understanding and management of symptoms that 
impair quality of life (QoL). Cognitive impairment is a common and debilitating feature 
of MS which is associated with worse prognosis and functional difficulties (Amato et 
al., 2010; Chiaravalloti & DeLuca, 2008; Langdon, 2011). It has been suggested that 
the cerebellum plays an important role in cognition (Koziol et al., 2014). Cerebellar 
damage in MS greatly contributes to disease-related impairment and is associated 
with poor response to symptomatic treatment and rehabilitation (Langdon & 
Thompson, 1999; Weier et al., 2015). As a result, there is a considerable amount of 
interest in the relationship between the cerebellum and cognition in MS. For these 
reasons, it is important to understand the contribution of the cerebellum to cognitive 
performance and other related factors in MS. 
2.2.1 Multiple Sclerosis 
MS is an inflammatory, demyelinating disease of the central nervous system that is 
characterised by the presence of lesions in the brain and spinal cord, which leads to 
axonal demyelination (Ransohoff, Hafler, & Lucchinetti, 2015). The damage of myelin 
results in loss of saltatory conduction and the disease appears to target the myelin 
and oligodendrocytes before neurons are later lost. The cause of the disease is 
unknown; although, it is widely considered to involve a combination of environmental 
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and genetic factors as well as an immune-mediated process (Compston & Coles, 2008; 
Lobeck, 2002). Typically the disease develops between the ages of 20 – 40 years and 
women are twice as likely to develop the disease as men (Mackenzie et al., 2014). 
Based on epidemiologic and genetic data, MS is proposed to be caused by some 
environmental agent that triggers the disease in susceptible individuals. The trigger is 
unknown, but likely to be a viral or bacterial infection that occurs in childhood (Male, 
2013). The onset of MS can be described as a ‘perfect storm’, whereby multiple factors 
combine to create a weakness in the brain and an uncontrolled immune response.  
2.2.2 Mechanisms of MS 
The precise mechanisms of MS initiation, development and progression remain 
elusive; however, inflammation and neurodegeneration are both considered to play a 
key role (Dendrou, Fugger, & Friese, 2015). It has been proposed that early stages of 
MS begin with the formation of acute inflammatory lesions characterised by 
breakdown of the blood-brain barrier (BBB) and invading peripheral immune cells 
(Male, 2013). Migration of autoreactive lymphocytes (T-cells) and macrophages 
activate various inflammatory processes that cause damage to oligodendrocytes, the 
cells responsible for support and insulation of axons through the creation of myelin 
(Compston & Coles, 2008). Damage to the integrity of the axon disrupts 
communication, leading to a range of clinical signs and symptoms. Although there is 
variability in terms of the degree of damage to myelin and axons in early stages, there 
is little overt damage to the brain and spinal cord outside the focal lesions. Moreover, 
recovery in early stages is possible due to a process of remyelination by which new 
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myelin sheaths are created; however, this process becomes increasingly inadequate 
and eventually fails leading to enduring signs and symptoms (Chari, 2007).  
It has been suggested that chronic inflammation drives processes that eventually lead 
to neurodegeneration (Dendrou et al., 2015; Friese, Schattling, & Fugger, 2014). 
Neuroaxonal injury, due to a cascade of events such as oxidative stress and ionic 
imbalance combined with a failure of neuroprotective and regenerative mechanisms, 
culminates in cell death and loss of neuronal activity. This irreversible loss causes brain 
atrophy and increased functional disability.  
2.2.3 Diagnosis and Subtypes 
The diagnosis of MS is based on clinical features as there is no one definitive test. The 
most recent criteria were developed by a panel of experts based on a revision of the 
McDonald (2001) criteria (Thompson et al., 2018). These criteria are used to confirm 
or dispute a diagnosis and based on evidence of damage to the central nervous system 
in time and space, often incorporating magnetic resonance imaging (MRI), and states 
that neurological disturbance must occur on at least two occasions (lasting more than 
24 hours), more than 30 days apart. 
Although there are several variations, MS can be broadly divided into three main 
forms: Relapsing-Remitting MS (RR-MS), secondary progressive MS (SP-MS) and 
primary progressive MS (PP-MS).  
(i) Relapsing-Remitting MS (RR-MS) 
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The most common subtype, accounting for approximately 85% of MS patients, is the 
relapsing remitting form (Dendrou et al., 2015). The disease course begins with an 
episode of neurological dysfunction causing an increase in disability, followed by a 
remission period and complete or partial recovery. Inadequate recovery leads to 
residual disability and eventually, disability accumulates with recurrent bouts of 
relapse and remission over time (Leary, Porter, & Thompson, 2005). 
(ii) Secondary Progressive MS (SP-MS) 
Out of the 85% of patients with RR-MS, approximately 80% go on to develop the 
secondary progressive form (Dendrou et al., 2015). The disease pattern is 
characterised by progressive neurological decline with brain atrophy and increased 
axonal loss following an initial relapsing course (Leary et al., 2005).  
(iii) Primary Progressive MS (PP-MS) 
PP-MS accounts for 10 - 15% of the MS population which features a progressive 
decline from the outset without periods of relapse or remission (Dendrou et al., 2015).  
The average age tends to be older and comparatively more men are affected (Leary et 
al., 2005).  
2.2.4 Clinical Features 
The clinical manifestations of MS are not generally disease specific, instead an 
overabundance of signs or symptoms can occur affecting cognitive, motor, sensory, 
visual, and autonomic systems (Compston & Coles, 2008). As such, MS can be defined 
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as a heterogenous condition and there is considerable diversity in the experience of 
patients with MS. Conversely, certain features such as Charcot’s triad of tremor, 
nystagmus and dysarthria are distinctive of MS (Weier et al., 2015). Other common 
symptoms include presentations of fatigue, visual deficits and paresis (Lublin, 2005). 
Interestingly, invisible or ‘hidden’ symptoms of MS including fatigue, pain and 
cognitive changes were found to be more predictive of subjective health distress than 
visible symptoms such as tremor and speech difficulties (White, White, & Russell, 
2008). In addition, research investigating the lived experiences of people with MS also 
highlighted the difficulties of these invisible symptoms and the challenges they pose 
in daily activities (MS Society, 2017).  
2.2.5 Cognition 
Cognition is the mental action or process of gathering knowledge that is acquired 
through learning or experience. It encompasses complex skills such as attention, 
perception, language and reasoning. Some of these skills decrease with normal aging; 
although, many factors can result in greater than expected cognitive impairment 
including neurological conditions such as MS (Raz & Rodrigue, 2006). Furthermore, 
cognitive dysfunction is closely associated with adverse outcomes on a range of daily 
activities (Chiaravalloti & DeLuca, 2008).  
 
2.2.6 Cognitive Impairment in MS 
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The study of cognition in MS has increased exponentially over the last two decades 
due to increased awareness of the profound impact of impaired cognitive functioning. 
It is estimated that 43% - 70% of patients with MS experience cognitive impairment 
(Chiaravalloti & DeLuca, 2008). Furthermore, the pattern of cognitive impairment is 
not uniform: the typical cognitive profile of MS reveals impairments in information 
processing speed (IPS), memory and executive functioning skills, with relative 
preservation of verbal skills (Langdon, 2011). Although disease duration is not always 
associated with cognitive impairment, longitudinal studies have found that cognitive 
impairment at diagnosis predicts disability progression and poor clinical outcomes 
(Moccia et al., 2016; Pitteri, Romualdi, Magliozzi, Monaco, & Calabrese, 2016).  
Cognitive impairment tends to be progressive with limited evidence of recuperation. 
One long-term longitudinal study, which followed 50 patients with MS over a 10-year 
period, found that 26% had mild or moderate impairment at baseline, and by the end 
of the follow-up period that number had increased to 56% (Amato, Ponziani, Siracusa, 
& Sorbi, 2001). Correspondingly, those with preserved cognition fell from 74% to 44% 
by the end of the study. Other short-term longitudinal studies have found similar 
findings. For example, a recent study evaluated the sensitivity of the Symbol Digit 
Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) to detect 
cognitive impairment at a 1-year follow-up in RR-MS (López-Góngora, Querol, & 
Escartín, 2015). At baseline, 27.6% were classified as cognitively impaired, and at 1 
year, that increased to 31.6%. The study demonstrated that even relatively short-term 
longitudinal studies have the potential to detect changes in cognition and replicate 
the pattern of progression found in longer observations. A further review of 
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longitudinal studies monitoring cognitive functioning in MS concluded that incipient 
cognitive decline was the major predictor of further cognitive decline (Amato, Zipoli, 
& Portaccio, 2006). 
Although a range of cognitive domains are impaired in MS, deficits in IPS are 
considered the most frequent (DeLuca, Chelune, Tulsky, Lengenfelder, & Chiaravalloti, 
2004). IPS is defined as the efficiency of cognitive function and often involves working 
memory. Analysis of MS patient performance on a range of cognitive tests has implied 
that IPS is the unitary underlying deficit (Langdon, 2011), and therefore forms a 
valuable component of intact cognitive functioning. The nature of IPS impairment in 
MS suggests that it relies on the integrity of neural networks - complex 
interconnections between cortical and deep grey matter structures, supported by 
white matter projections (G. DeLuca, Yates, Beale, & Morrow, 2015; Ruet et al., 2014). 
The overarching consensus from research suggests that damage to neural networks 
would adversely affect cognitive efficiency as measured by IPS.  
2.2.7 Effect of Cognitive Impairment on Daily Living 
Several studies indicate that MS patients with cognitive deficits are compromised in 
many everyday activities including impaired social functioning (G. DeLuca et al., 2015) 
and continued employment (Honarmand, Akbar, Kou, & Feinstein, 2011). Evidence 
also suggests that poor QoL measures are associated with cognitive deficits (Cutajar 
et al., 2000). However, this finding has not always been replicated (Baumstarck-Barrau 
et al., 2011).  After accounting for multiple predictors, a study by Benedict et al (2005) 
found QoL was most strongly predicted by measures of depression, whereas cognitive 
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impairment predicted vocational status. The overwhelming message is that intact 
cognitive functioning is important for activities of daily living. 
2.2.8 Other Factors Contributing to Cognition 
There are several factors that have the potential to affect neuropsychological test 
interpretation. For example, research has consistently demonstrated a negative 
association between depression and cognitive functioning in MS (Arnett, Barwick, & 
Beeney, 2008). Depression symptomatology in MS has been linked with reduced 
performance on measures of IPS, visual memory and executive functions (Morrow, 
Rosehart, & Pantazopoulos, 2016; Portaccio, 2016). Many of these deficits resemble 
the cognitive profile described above and thus highlights the challenge in 
disentangling contributions to performance. In addition, premorbid ability and fatigue 
have also been identified as factors that may influence performance (Benedict et al., 
2002). Within this context, it is important these potentially confounding variables 
need to be considered when reviewing studies of cognition in MS. 
 
2.2.9 Organisation of the Cerebellum 
The cerebellum occupies the posterior cranial fossa and attached to the brain stem by 
the superior, middle and anterior cerebellar peduncles; thereby providing multiple 
connections to various regions of the brain (Roostaei, Nazeri, & Sahraian, 2014). It 
consists of two cerebellar hemispheres, separated by the vermis, and divided into 
three lobes: anterior, posterior and flocculonodular. Each lobe is considered to have 
 27 
 
 
distinct functions. The cerebellum encompasses almost 80% of the total brain 
neurons, yet only represents 10% of the intracranial space (Herculano-Houzel, 2010).  
2.2.10 Cerebellar Function 
The cerebellum plays a vital role in many aspects of human behaviour and it is widely 
accepted that the function of the cerebellum is to integrate, regulate, and coordinate 
motor processes. However, converging evidence has demonstrated the importance of 
the cerebellum for other functions, including participation in a variety of cognitive 
functions (Koziol et al., 2014; Roostaei et al., 2014).  For example, neuroimaging 
research has shown that different regions of the cerebellum form distinct cortico-
cerebellar circuits with specific areas of the cerebral cortex as well as cerebellar 
involvement in higher-order cognitive processes (e.g. executive functions) (Balsters, 
Laird, Fox, & Eickhoff, 2014; Middleton & Strick, 1994; Stoodley & Schmahmann, 
2010). 
Further evidence to imply a role for the cerebellum in cognition is demonstrated in 
the cerebellar cognitive affective syndrome (CCAS) (Schmahmann & Sherman, 1998). 
The syndrome is characterised by acquired focal lesions and sequalae can include 
cognitive impairment such as executive dysfunction, impaired working memory, and 
visuospatial deficits, as well as personality and affective changes. Furthermore, a 
topographical distinction between anterior and posterior lobe damage has been 
proposed, with the latter being associated with changes in cognition (Stoodley & 
Schmahmann, 2010). From an anatomical and functional viewpoint, evidence suggests 
that the cerebellum is integrated into various neural networks, and consequently, 
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damage of either the cerebellum or related areas can affect a multitude of brain 
functions.  
2.2.11 Role of the Cerebellum in MS 
MS often has a predilection for the cerebellum. A broad range of clinical signs and 
symptoms of MS arise from lesions within the cerebellum and associated areas such 
as tremor, gait ataxia and poor coordination of voluntary movements (Weier et al., 
2015). To exemplify, the role of the cerebellum in motor function is aptly 
demonstrated by performance on motor tasks such as the Nine-hole Peg Test (NHPT), 
which relies on cerebellar integrity. Research has found MS patients with higher 
cerebellar lesion load and increased atrophy performed worse on the NHPT compared 
with controls without cerebellar damage  (van de Pavert et al., 2016). It is estimated 
that 11% of MS patients report cerebellar symptomatology as the predominant 
disease feature (Rot, Ledinek, & Jazbec, 2008). Furthermore, a large-scale study of 
patient relapses found that cerebellar relapse accounted for approximately 10% of all 
relapses (Kalincik et al., 2014). Undoubtedly, the cerebellum in MS contributes to a 
range of networks, in part due to the numerous connections to other parts of the 
central nervous system. Unfortunately though, cerebellar signs also tend to be more 
persistent and contribute to poorer outcomes (Amato & Ponziani, 2000). 
Given the importance of the cerebellum in MS, there has been a growing interest in 
the contribution of the cerebellum to cognition. Syndromes such as CCAS and the 
cerebellar topographical organisation indicate cerebellar damage in MS is likely to 
contribute to cognitive impairment. This premise has also been supported by recent 
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studies of cognition in MS patients. For example, Weier et al (2014) demonstrated a 
significant association between cerebellar lesion and atrophy with Paced Auditory 
Serial Addition Task (PASAT) and Symbol Digit Modalities Test (SDMT), both measures 
of IPS. However, this finding has not always been replicated (Cerasa et al., 2013). 
Instead, Cerasa et al concluded that cognitive impairment was related to grey matter 
atrophy in specific cortical regions connected to the cerebellum. Despite their 
different conclusions, both studies highlight a role of the cerebellum in cognition and 
the importance of the integrity in cortico-cerebellar circuits. 
Several theories have attempted to explain how the cerebellum participates in 
cognition. A recent consensus paper described the cerebellum as being critical for the 
modulation of sensorimotor and cognitive functions by way of multiple cortico-
cerebellar loops, controlling diverse streams of information underlying a wide range 
of functional domains (Koziol et al., 2014). It is considered that the presence of these 
functionally distinct cortico-cerebellar loops disencumber cortical regions by reducing 
the cognitive load, so that attention can focus on higher cognitive tasks such as motor 
planning or reasoning (Balsters et al., 2014; Stoodley, 2012).  
Of particular interest is a model describing the role of the cerebellum as having the 
ability to encode internal models of mental representations (Ito, 2008). An internal 
model is a neural representation of the external world (Ito, 2012). Accordingly, during 
tasks such as voluntary movement, the cerebellum can develop and hold a 
representation of information developed in the motor cortex during motor acquisition 
and use the internal model to perform precise movement without external feedback 
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or even conscious awareness. Support for the model is underpinned by clinical 
observations of normal control subjects and patients with cerebellar dysfunction 
(Koziol et al., 2014), however the model remains contentious. 
There is a growing literature indicating cerebellar involvement in cognition in MS, 
however whether cerebellar involvement represents a distinct cognitive profile in MS 
remains unknown. In addition, the specificities of any relationship are not fully 
determined. As such, there is justification for a systematic review to investigate the 
contribution of the cerebellum to cognitive functioning and other-related variables in 
MS.   
2.3 Summary and Objectives 
Cognitive impairment is a common and debilitating feature of MS; therefore, it is 
important research efforts focus on understanding factors that contribute to cognitive 
deficits. It has previously been established that damage to the cerebellum in MS is 
associated with disease-related impairment and poorer rehabilitation outcomes. 
Consequently, there is growing interest in the relationship between the cerebellum 
and cognition in MS. The aim of this review is to measure the impact of cerebellar damage 
on cognition and other-related variables in MS. The review will pay attention to whether 
there is a specific cognitive profile for MS patients with cerebellar damage, which in 
turn, may have implications for differential treatment responses. Furthermore, if any 
relationship exists, the review will elucidate the nature of the relationship based on 
proposed mechanisms. Although several phenotypes of MS exist, the systematic 
review will predominately focus on RR-MS, the most common pattern of progression. 
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The objective is to conduct a systematic review of all studies published in English that 
investigated the relationship between cerebellar function and cognitive performance 
and other related variables such as fatigue in RR-MS. The review will also evaluate the 
content and methodological quality of the studies included. To the author’s 
knowledge, this is the first systematic review to adopt the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to explore the 
influence of cerebellar involvement on the cognitive performance of RR-MS.   
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2.4 Method 
2.4.1 Literature Search 
To identify relevant studies, a literature search was conducted across four online 
literature databases and trial registers (PubMed, Web of Science, Google Scholar and 
OVID) between the 25th – 28th August 2017 using the search terms in Table 1. Previous 
meta-analyses, systematic reviews and leading journals investigating the role of 
cerebellum in cognition with MS patients were also searched. 
Table 1 Search terms used for literature review 
Search terms 
 
 
 
“multiple sclerosis” OR “relapsing-remitting 
multiple sclerosis” 
AND 
“cognitive deficits” OR “cognition” OR “cognitive 
impairment” OR “cognitive dysfunction” OR 
“memory” OR “information processing” OR 
“attention” OR “executive functioning” 
AND 
“Cerebellar damage” OR “cerebellar dysfunction” 
OR “cerebellum damage” OR “cerebellar 
impairment” OR “cerebellum*” 
 
2.4.2 Eligibility Criteria 
The inclusion criteria for the studies in the present review were published, peer-
reviewed in English language measured the impact of cerebellar function to cognitive 
performance in individuals with RR-MS with no age limit. Evidence of cerebellar 
involvement was verified through the presence of lesions in the cerebellum as 
demonstrated by neuroimaging techniques or the use of validated clinical assessment 
measures that were indicative of cerebellar damage (e.g. Cerebellar Functional System 
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Score, Kurtzke, 1983). No date restriction was applied. No restrictions were placed on 
the type or presence of a control group. Studies were included if sufficient data were 
available for analysis (unavailable information was requested from authors and 
included if obtained) and the number of participants in any condition was required to 
be more than 5 at any given point. Studies that pooled individuals with other types of 
MS (e.g. PP-MS) were excluded unless separate data for individuals with RR-MS were 
provided.  
Studies were required to have used at least one neuropsychological outcome 
measure. All primary and secondary neuropsychological outcomes that measured 
performance of different cognitive abilities or non-cognitive outcomes (e.g. fatigue or 
mood) were included. Each study was independently screened, selected for inclusion 
and data extracted by one author (JC). Any ambiguity with data collection was 
resolved through discussion with another researcher (DL). 
2.4.3 Study Selection 
All articles gathered during the literature search were assessed for eligibility. 
Irrelevant articles were excluded based on the title and abstract, and duplicates 
removed before those remaining were subject to a full-text review independently by 
one reviewer (JC) and verified by another (DL). In total, 14 articles met the inclusion 
criteria for data extraction (see Fig. 1).  
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Figure 1 PRISMA Flow chart of the study selection process 
2.4.4 Data Extraction 
The following information was extracted from the final 14 articles: 
- Characteristics of study participants: means and standard deviations (SD) for 
age, gender, level of education, MS phenotype, disease duration and Expanded 
Disability Status Scale (EDSS) when stated, were independently extracted. 
- Characteristics of each study: the design and methodology were recorded. 
Information about the nature of the investigation and theories of underlying 
mechanisms was also noted. 
Articles identified after search (n = 564) 
• Web of Science: 44 
• PubMed: 151 
• Ovid: 360 
• Google Scholar: 9 
Articles excluded following application of 
exclusion criteria (n = 490) 
Full text articles assessed for eligibility (n = 21) 
Exclusion based on full text (n = 7) 
 
• Review (n = 3) 
• No MS group (n = 1) 
• Pooled MS phenotypes (n = 2) 
• No neuropsychological measures (n 
= 1) 
Articles included for review (n = 14) 
Articles after duplicates removed (n = 510) 
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- Outcome measures: the use of any neuropsychological outcome measure or 
other related-variable was recorded. 
- Key findings: in relation to the objective of understanding the contribution of 
the cerebellum to cognitive impairment in MS, all relevant clinical, 
neuroimaging and neuropsychological findings were extracted and 
summarised. 
2.4.5 Assessment of Study Quality 
The Effective Public Health Practice Project (EPHPP) was used to assess study 
methodological quality (Thomas, Ciliska, Dobbins, & Micucci, 2004). The tool utilises a 
6-item scale (selection bias, study design, confounders, blinding, data collection 
method and withdrawal and dropout) to provide an overall quality rating. Two authors 
independently rated each study (JC & DL). If a study scored a weak rating in each 
domain, the study would be excluded from the systematic review. The EPHPP tool was 
selected due to strengths in inter-rater reliability and suitability for systematic reviews 
(Armijo-Olivo, Stiles, Hagen, Biondo, & Cummings, 2012).  
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2.5 Results 
2.5.1 Study Quality 
The quality of each study was evaluated regarding certain methodological aspects and 
summarised in Table 2. The overall quality of each study included in the review was 
strong, with only three studies scoring a fair quality rating (Cerasa et al., 2012, 2013; 
Rocca et al., 2012). It was noted that most studies did not provide information on 
blinding procedures, increasing the risk of detecting and reporting bias. In contrast, all 
studies scored a strong rating on data collection methods indicating that all outcome 
measures used were reliable and valid. No studies were excluded based on the quality 
rating. 
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Table 2 Quality ratings for studies included in the systematic review 
Lead Author and 
Year 
Se
le
ctio
n
 B
ias 
Stu
d
y D
e
sign
 
C
o
n
fo
u
n
d
e
rs 
B
lin
d
in
g 
D
ata 
C
o
lle
ctio
n
 
M
e
th
o
d
 
W
ith
d
raw
als 
an
d
 D
ro
p
o
u
t 
O
ve
rall 
Q
u
ality 
R
atin
g 
Cerasa, 2012 Fair Strong Strong Fair Strong Weak Fair 
Cerasa, 2013 Strong Strong Strong Fair Strong Weak Fair 
Cirillo, 2015 Fair Strong Fair Fair Strong Strong Strong 
D'Ambrosio, 2017 Strong Strong Strong Fair Strong Strong Strong 
Damasceno, 2014 Strong Strong Strong Fair Strong Strong Strong 
Fartaria, 2017 Strong Fair Strong Fair Strong Strong Strong 
Kolb, 2014 Strong Strong Strong Fair Strong Strong Strong 
Lesage, 2010 Strong Strong Strong Fair Strong Strong Strong 
Rocca, 2012 Strong Strong Strong Weak Strong Strong Fair 
Romascano, 2015 Strong Strong Strong Fair Strong Strong Strong 
Ruet, 2014 Strong Strong Strong Fair Strong Strong Strong 
Valentino, 2009 Strong Strong Strong Fair Strong Strong Strong 
Weier, 2014 Fair Fair Strong Fair Strong Strong Strong 
Weier, 2016 Strong Strong Strong Fair Strong Strong Strong 
Overall quality rating: Strong = no weak ratings; Fair = one weak rating; Weak = two or more weak 
ratings 
2.5.2 Study Participants 
The total amount of case group patients from all studies was 433. The sample size for 
each study was variable, ranging from 20 to 60 patients in the case group. All studies 
applied formal criteria to meet the diagnosis of RR-MS including the revised McDonald 
criteria (Polman et al., 2011). Two studies investigated paediatric populations (Cirillo 
et al., 2016; Weier et al., 2016), reporting a similar average age, although differing 
ranges of disease duration. The rest of the studies investigated adult populations, with 
an average age of 38.6 years within the case group. Except for Kolb et al (2014), all 
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studies provided a ratio of male/female, which indicated an average of 74% in favour 
of female patients which reflects wider prevalence rates. The lack of reporting in 
patient’s years of education precluded mean calculations, although the available data 
suggested most patients had at least secondary school education.  There was disparity 
regarding disease duration of the case adult patients, ranging from an average mean 
per study of 2 to 12.1 years. When reported, the average EDSS score was 2.0, 
indicating that case participants tended to report minimal disability. However, there 
was a wide range of EDSS across studies (0 to 7.5), which would suggest there was 
diversity across patients. Furthermore, four studies used RR-MS with cerebellar signs 
(RR-MSc) as the MS phenotype of interest. Two of those studies (Cerasa et al., 2012, 
2013) used structural MRI as part of the criteria for defining RR-MSc, whereas the 
other two studies used evidence of cerebellar symptoms as indicated by an EDSS 
cerebellar functional systems score. Finally, two studies provided no details of a clear 
inclusion or exclusion criteria (Romascano et al., 2015; Weier et al., 2014), whereas 
the others provided at least a reference to inclusion criteria. Overall, the case 
participants were a largely heterogenous group involving predominately adult females 
with minimal disability with clear evidence of RR-MS.  
Nearly all studies employed a control group. The control group participants were 
either healthy controls matched on certain variables (n = 8) or RR-MS patients without 
cerebellar signs (RR-MSnc) (n = 4). It is difficult to comment further on the 
methodological quality and adequacy of the control groups given the disparity 
between studies as well as incomplete data provided. The available demographic 
information reflects similar characteristics of the case group. 
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2.5.3 Study Methods 
The most common study design was controlled clinical trial often incorporating the 
use of neuroimaging techniques. No studies employed a randomised control design. 
2.5.4 Neuropsychological Measures 
Table 3 summarises the 19 different neuropsychological measures utilised to measure 
cognitive performance. A range of specific cognitive domains were tested, with 
information processing speed the most commonly investigated domain. The tests 
most commonly used were (in order): SDMT, PASAT (both measures of IPS) and 
COWAT (verbal fluency). There was evidence that several studies employed the use of 
a recommended test battery such as the Brief International Cognitive Assessment for 
MS (BICAMS) (Langdon et al., 2012). No studies reported any follow-up data for any 
outcome measure. 
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Table 3 Brief description of specific neuropsychological outcome measures used by studies 
from the systematic review 
Neuropsychological 
Outcome Measures 
Domain Brief Description Study (Lead author) 
California Verbal 
Learning Test 
Verbal 
Memory 
Participants repeat a list of 
16 unrelated words over 
five different trials. After 
each trial, the participant is 
asked to recall as many 
words as possible.  
Kolb, 2014 
Computerised Speed 
Cognitive Test 
Processing 
Speed and 
Attention 
The test uses a 
digit/symbol substitution 
task. Participants are 
required to record digits 
that correspond to 
symbols presented on the 
computer screen. 
Ruet, 2004 
Controlled Oral Word 
Association Test 
Verbal 
fluency 
Participants generate as 
many words in three one-
minute naming trials from 
a given letter or category.  
Ceresa, 2012; Ceresa, 2013; 
Fartaria, 2017; Romascano, 
2015; Ruet, 2004; 
Valentino, 2009 
Digit Span Working 
Memory 
Sequence of digits is read 
aloud. Subjects asked to 
immediately recall digits in 
the correct order. If 
correct, a sequence with 
an additional digit is 
presented. 
Kolb, 2014; Ruet, 2004 
Judgement of Line 
Orientation 
Visuospatial 
Skills 
The test measures a 
participant's ability to 
match the angle and 
orientation of lines in 
space to provide an 
indication of visuospatial 
skills. 
Ceresa, 2012; Ceresa, 2013; 
Valentino, 2009 
Mini-Mental State 
Examination 
General 
Cognition 
A 30-point questionnaire 
used to estimate severity 
of cognitive impairment 
including orientation and 
memory functions. 
Ceresa, 2012; Ceresa, 2013 
Modified Card Sorting 
Test 
Executive 
Function 
A shortened version of the 
Wisconsin Card Sorting 
Test. The participant 
tasked with matching cards 
without guidance; 
however, participant is 
told whether a particular 
match is right or wrong. 
Ceresa, 2013; Valentino, 
2009 
 41 
 
 
Neuropsychological 
Outcome Measures 
Domain Brief Description Study (Lead author) 
Paced Auditory Serial 
Addition Test 3 
Processing 
Speed 
The examiner presents 
numbers every three 
seconds (recorded for 
standardisation), and the 
participant must add this 
number to the previous 
number presented. 
Ceresa, 2012; D'Ambrosio, 
2017; Damasceno, 2014; 
Kolb, 2014; Lesage, 2010; 
Romascano, 2015; Ruet, 
2004; Fartaria, 2017; 
Weier, 2014 
Rey Auditory-Verbal 
Learning Test 
Verbal 
Memory 
Participants repeat a list of 
15 unrelated words over 
five different trials. 
Another list of 15 
unrelated words are given 
and the client must again 
repeat the original list of 
15 words and then again 
after 30 minutes. 
Ceresa, 2013; Valentino, 
2009 
Rey-Osterrieth Complex 
Figure Test 
Spatial 
Memory 
Participants asked to 
reproduce a complicated 
line drawing, first by 
copying it freehand, and 
then drawing from 
memory. 
Ceresa, 2013; Valentino, 
2009 
Selective Reminding 
Test - Long term 
storage, consistent long 
term retrieval, delayed 
recall 
Verbal 
Memory 
Task requires participant 
to recall a list of 12 
unrelated words over a 
number of trials. Words 
not recalled are presented 
again in subsequent trials 
until participant correctly 
recalls all 12 words on 
three consecutive trials, or 
until 12 trials have been 
completed. 
Ceresa, 2012; Cirillo, 2015; 
Fartaria, 2017; Romascano, 
2015; Ruet, 2004 
Spatial Recall Test - 
immediate recall, 
delayed recall 
Visual 
Memory 
Participants are required 
to reproduce patterns 
from a checkboard over 
three learning trials. 
Ceresa, 2012; Romascano, 
2015; Ruet, 2004; Fartaria, 
2017 
Stroop Test Executive 
Function 
A measure of a 
participant's ability to 
name colours of different 
stimuli within a timed 
paradigm 
Ceresa, 2012; Rocca, 2012; 
Ruet, 2004 
Symbol Digit Modalities 
Test 
Processing 
Speed 
In this test, symbols are 
paired with numbers. 
Following a practice phase, 
participants are required 
to record numbers that 
correspond to figures 
presented within the test-
sheet. 
Ceresa, 2012; Ceresa, 2013; 
Cirillo, 2015; D'Ambrosio, 
2017; Damasceno, 2014; 
Kolb, 2014; Lesage, 2010; 
Romascano, 2015; Fartaria, 
2017; Valentino, 2009; 
Weier, 2014; Weier, 2016 
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Neuropsychological 
Outcome Measures 
Domain Brief Description Study (Lead author) 
Trail Making Test Executive 
Function 
The task requires 
participants to ‘connect 
the dots’ in two parts, 
firstly numerically and 
secondly, alphanumerically 
Cirillo, 2015; Weier, 2016;  
Verbal and Spatial 
Reasoning Test 
Verbal 
Reasoning 
Using a multiple-choice 
format, participants are 
required to complete six 
sections of inductive 
reasoning problems 
Lesage, 2010 
Wechsler Abbreviated 
Scale of Intelligence - 
subtests (Vocabulary, 
Similarities) 
IQ A test of general cognitive 
ability, made up of several 
subtests measuring various 
cognitive abilities. 
Combined the subtests 
provide an estimate of a 
Full-Scale Intelligence 
quotient (FSIQ). Subtests 
can be used to provide an 
estimate of other abilities 
such as verbal 
comprehension.  
Cirillo, 2015; Lesage, 2010; 
Weier, 2016 
 
2.5.5 Other Variables 
Table 4 summarises the 8 non-neuropsychological outcome measures. The most 
commonly tested area was motor function, with 6 of the studies using the NHPT. 
Interestingly, no studies investigated subjective Quality of Life. In addition, Table 2 
indicates that 12 studies investigated the role of the cerebellum using neuroimaging 
techniques including structural MRI. A review of the key findings indicated that lesion 
load and cerebellar volume were most often assessed. 
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Table 4 Brief description of other outcome measures used by studies from the systematic 
review 
Outcome Measure Domain Brief Description Study (Lead author) 
Nine-Hole Peg Test Motor 
Function 
The test consists of a board with 9 
holes. Pegs must be inserted and 
removed as quickly as possible, 
providing quantification of extremity 
function and physical disability. 
Cirillo, 2015; 
D'Ambrosio, 2017; 
Damasceno, 2014; 
Lesage, 2010; 
Romascano, 2015; 
Weier, 2014 
Antisaccade Task Visual 
Motor 
Function 
The task involves the recording of 
saccade eye movement as participant 
is required to inhibit the reflexive 
saccade to a stimulus.  
Kolb, 2014 
Beck Depression 
Inventory 
Mood Participants answer a 21-question 
multiple-choice self-report inventory 
to measure severity of depression. 
Ceresa, 2012 
Beery Visual Motor 
Integration 
Visual 
Perception 
Identifies significant difficulties in 
integrating or coordinating visual 
perceptual and motor (finger and 
hand movement) abilities. 
Weier, 2016 
Fatigue Scale for 
motor and 
cognitive fatigue 
Fatigue The test uses a Likert-type 5-point 
scale on a 20-item questionnaire to 
measure fatigue on two subscales 
(mental and physical fatigue). 
Romascano, 2015; 
Weier, 2014 
Fatigue Severity 
Scale 
Fatigue A 9-statement measure of fatigue that 
allows for discrimination with 
depression. Participants rate how 
much they endorse these from 1-7 (1 
strongly disagree, to 7 strongly agree). 
Lesage, 2010 
Grooved Pegboard 
test 
Motor 
Function 
The test consists of a pegboard with 
25 holes. Pegs must be inserted into 
randomly positioned holes at the 
correct orientation, due to a key on 
the side of pegs. 
Weier, 2016 
Hospital Anxiety 
and Depression 
Score 
Mood A 14-item scale with seven statements 
measuring anxiety and depression. 
The scale reduces the focus on aspects 
of anxiety and depression that are 
common somatic symptoms of illness. 
Fartaria, 2017; 
Lesage, 2010; 
Romascano, 2015 
 
2.5.6 Important Findings 
The salient findings from each study are reported in Table 5. Overall, there was 
evidence of cognitive impairment in patients with RR-MS, specifically in the domains 
of IPS and executive functions. Furthermore, nearly all studies indicate support for the 
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contribution of the cerebellum to cognitive performance as well as support for a 
differential cognitive profile between RR-MS patients with cerebellar symptoms and 
those without cerebellar symptoms. In addition, findings also showed strong evidence 
of cerebellar involvement in tests of motor function. Although there was limited 
information, it does not appear that the cerebellum contributes significantly to mood 
or fatigue symptoms.  
2.5.7 Attention and Information Processing Speed 
Patients with evidence of cerebellar signs demonstrated deficits on measures of 
attention and IPS. This was observed in studies that compared IPS performance to a 
healthy control group (Cerasa et al, 2012; Damasceno et al, 2014; Kolb at al, 2014; 
Weier et al 2016), although this finding was not always consistent (Lesage et al, 2010; 
Romascano et al, 2015). In addition, three studies that compared performance to 
those with RR-MS without cerebellar damage also indicated evidence of IPS deficits 
(Cerasa et al 2013; Valentino et al, 2009; Weier et al, 2014).  
2.5.8 Executive Function 
Focal tests of executive function including verbal fluency demonstrated some 
evidence of deficits in patients with cerebellar damage. Several studies reported lower 
performance on the WLG, Stroop and TMT-B tests when compared to either healthy 
controls or RR-MSnc (Ceresa et al, 2012; Ceresa et al, 2013; Fartaria et al 2017; Rocca 
et al, 2012; Valentino et al 2009; Weier et al 2016). In contrast, two studies did not 
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report any differences in executive functioning (Romascano et al 2015; Ruet et al 
2004).  
2.5.9 Memory 
There was minimal evidence to suggest that the cerebellum contributes to either 
verbal or non-verbal memory. Several studies indicated that there was no difference 
between patients with cerebellar signs and healthy controls or RR-MSnc on a range of 
memory tasks (Ceresa et al, 2012; Romascano et al 2015; Ruet et al 2004; Valentino 
et al 2009). Only one study found a significant difference on performance on spatial 
memory, but not verbal memory (Ceresa et al, 2013). Two studies fail to provide 
sufficient information to infer any differences on memory tests (Cirillo et al 2015; Kolb 
et al, 2014). 
2.5.10 Motor Function 
There was strong evidence to indicate cerebellar involvement in motor function. 
Nearly all studies that included motor functioning as a measure, typically the NHPT, 
demonstrated that cerebellar signs resulted in poorer performance (e.g. Cirillo et al, 
2015; Romascano et al, 2015; Weier et al, 2014). Furthermore, cerebellar lesion load 
and volume were repeatedly found to predict performance (e.g. D'Ambrosio at al, 
2017; Damasceno et al, 2014; Lesage et al, 2010).  
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2.5.11 Mood  
It was harder to infer the prevalence of mood difficulties from the results in part due 
to the limited number of studies that investigated the domain. Of the studies that 
included a mood outcome measure, two studies found no evidence significant mood 
difficulties in individuals with cerebellar signs (Ceresa et al, 2012; Fartaria et al 2017), 
one study found individuals with RR-MS had significantly higher rates for trait anxiety, 
depression compared to control, however this was not correlated with cognitive 
performance (Lasage et al, 2010), and one study found a significant difference in 
depression symptoms between patients with MS compared to controls, however it 
appears scores were not clinically significant (Romascano et al, 2015). Therefore, there 
is minimal support that the cerebellar is involved in difficulties with affect.  
2.5.12 Fatigue 
All three studies that measured fatigue indicated higher rates of fatigue in individuals 
with RR-MS (Lasage et al, 2010; Romascano et al, 2015; Weier et al, 2014). Only one 
study found individuals with cerebellar signs had higher rates of fatigue than those 
without (Weier et al, 2014). However, differences were not correlated with cerebellar 
volumes. The results suggest the cerebellum does not substantially contribute to 
fatigue. In contrast, fatigue is likely to contribute to cognitive performance. 
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Table 5 Characteristics and main findings of studies included in the systematic review 
Study 
Study 
Type 
Objective Case Group  Control Group Main Findings 
Cerasa, 2012 
Case-
Control 
with MRI 
To investigate the 
influence of 
cerebellar signs in RR-
MS on specific 
cerebellar-cortical 
circuits 
Type = RR-MSc  
n = 12  
ratio = 83%  
age = 38.7 ± 13.5  
Edu = 12.5 (5-16)  
Dur = 98.4 ± 62.6 
(months)  
EDSS = 3 (1.5-4) 
Type = RR-MSnc  
n = 15  
ratio = 73%  
age = 35.6 ± 7.1  
Edu = 13 (8-7)  
Dur = 93.1 ± 69.2 
(months)  
EDSS = 2 (2-4) 
There were no significant differences in performance on any 
neuropsychological tests between patients with RR-MSc and RR-
MSnc. The presence of significant impaired performance was 
only in relation between RR-MSc and HC on measures of IPS 
(SDMT) and executive functioning (Stroop test), and both MS 
groups and HC on WLG. Cerebellar lesion load did not correlate 
with any neuropsychological outcome. 
Cerasa, 2013 
Case-
Control 
with MRI 
Investigation of 
neuroanatomical 
abnormalities in RR-
MSc and RR-MSnc 
Type = RR-MSc  
n = 12  
ratio = 83%  
age = 38.9 ± 8.7  
Edu = 13 (5-17)  
Dur = 12.1 ± 8.7  
EDSS = 2.5 (1-4)  
FSS = 4 ± 1.1 
Type = RR-MSnc 
n = 14 
ratio = 79%  
age = 38.6 ± 8.5  
Edu = 13 (95-17)  
Dur = 8.8 ± 4.4 
EDSS = 2 (1.5-4.5) 
FSS = 3.7 ± 1.6 
Patients within the RR-MSc group exhibited poorer performance 
on IPS (SDMT), verbal fluency (COWAT) and spatial memory tests 
(ROCFT) compared to RR-MSnc and HC. Within the RR-MSc 
group, grey matter volume loss in the frontal and temporal 
cortical areas were significantly correlated with performance on 
the SDMT and COWAT respectively. 
Cirillo, 2015 
Case-
Control 
with MRI 
Investigation of 
functional 
connections of the 
cerebellar dentate 
nuclei in paediatric 
RR-MS patients and 
correlations with 
clinical, cognitive and 
structural MRI 
measures 
 
Type = RR-MS 
n = 48  
ratio = 65%  
age = 14.9 (8.1-17) 
Edu = N/R  
Dur = 1.7 (0.1-8.1) 
EDSS = N/R 
 
Type = HC  
n = 27  
ratio = 59%  
age = 15.2 (8.5-17) 
Edu = N/R  
8 of the RR-MS patients were found to be cognitively impaired - 
defined as an abnormal performance on ≥ 3 tests of the Brief 
Neuropsychological Battery for Children (Portaccio et al, 2009). 
No further information is provided regarding the nature of the 
cognitive impairments. RR-MS patients who were cognitively 
impaired showed a widespread reduction in functional 
connections between the dentate nucleus and regions within the 
parietal, frontal and temporal lobes compared to both HC and 
cognitively preserved RR-MS patients. More generally 
comparisons between RR-MS patients and HC indicated 
functional connectively is influenced by disease duration and 
lesion volume. 
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Study 
Study 
Type 
Objective Case Group  Control Group Main Findings 
D'Ambrosio, 
2017 
Case-
Control 
with MRI 
To investigate the 
contribution of 
cerebellar sub-
regions to motor and 
cognitive 
performance in 
different phenotypes 
of MS using MRI 
Type = RR-MS  
n = 52  
ratio = 65%  
age = 43.3 ± 11.2  
Edu = 13.8 ± 3.7  
Dur = 8.2 (0-34)  
EDSS = 2 (1-6) 
Type = HC  
n = 32  
ratio = 43%  
age = 39.6 (8.4)  
Edu = 16.9 ± 2.6  
There was a significant difference between RR-MS and SP-MS on 
SDMT performance, which was largely accounted for by the SP-
MS group. No comparisons of cognitive performance on SDMT 
and PASAT-3 were made with HC. There were no significant 
differences in cerebellar volume between RR-MS and HC. When 
MS phenotypes were pooled, lower posterior cerebellar volume 
and brain lesion volume predicted poor cognitive performance. 
Damasceno, 
2014 
Case-
Control 
with MRI 
To investigate the 
cerebellar grey 
matter pathology in 
RR-MS on clinical and 
cognitive functioning 
Type = RR-MS  
n = 42  
ratio = 76%  
age = 30.52 ± 6.6  
Edu = 13.69 ± 1.83 
Dur = 6.4 ± 4.94  
EDSS = 2.5 (0-4) 
Type = HC 
n = 30 
ratio = 77%  
age = 29.52 ± 7.52 
Edu = 15.18 ± 0.77  
The presence of cerebellar lesions was found in 53.8% of the RR-
MS sample. A high burden of leukocortical lesions resulted in 
poorer performance on the PASAT-3 whereas greater volumes of 
intracortical lesions resulted in poorer performance on the 
SDMT. More generally, the RR-MS group performed significantly 
worse on the NHPT, PASAT-3 and SDMT when compared to HC 
after controlling for years of education. 
Fartaria, 2017 
Case 
with MRI 
The investigation of 
cerebellar pathology 
using ultra-high-field 
MRI and the 
contribute of MRI 
metrics to clinical and 
cognitive 
performance in RR-
MS 
Type = RR-MS  
n = 20  
ratio = 75%   
age = 34.9 (21-46) 
Edu = N/R  
Dur = 36.5 ± 21.8 
(months)  
EDSS = 1.5 (1-2) 
No control group       
Cerebellar lesion characteristics measured by superior MRI 
metrics established a significant correlation between a visual 
memory task (SRT - delayed recall) as well as motor performance 
(NHPT). No other correlations were found with cognitive 
measures within the Brief Repeatable Battery of 
Neuropsychological Tests, which included both the PASAT-3 and 
SDMT using images acquired at superior MRI. 
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Study 
Study 
Type 
Objective Case Group  Control Group Main Findings 
Kolb, 2014 
Case-
Control 
with MRI 
Investigation of the 
relationship between 
saccadic eye 
movements using an 
antisaccade paradigm 
and neurological 
abnormalities, 
cerebral damage and 
cognitive dysfunction 
in patients with RR-
MS 
Type = RR-MS  
n = 24  
ratio = N/R  
age = 47 (25-63) 
Edu = N/R  
Dur = 6 (2-18)  
EDSS = 3 (1-6) 
Type = HC  
n = 24  
ratio = N/R 
age = 41 (30-62)  
Edu = N/R 
Individuals with RR-MS performed worse than matched controls 
on an antisaccade paradigm, there was a significant negative 
correlation between the amount of antisaccadic errors and 
performance on IPS tests (PASAT-3 and SDMT). The number of 
antisaccadic errors was also significantly associated with 
cerebellar damage. The authors suggest that the cerebellar 
contributes to occular motor deficits in RR-MS and saccadic 
paradigms provide a surrogate measure of cognitive impairment.    
Lesage, 2010 
Case-
Control 
with MRI 
To investigate 
whether the 
cerebellar cortex 
plays a role in 
cognitive 
performance using 
functional MRI 
Type = RR-MS 
n = 19  
ratio = 79% 
age = 41.7 (29-55) 
Edu = N/R  
Dur = 6.4 
EDSS = N/R 
Type = HC  
n = N/R 
ratio = N/R  
age = 39.1 (26-55) 
Edu = N/R  
The RR-MS group performance was similar to the HC group on all 
cognitive tests, aside from the SDMT, where the HC group scored 
significantly higher. However, only 3 patients were considered 
impaired on the SDMT according to cut-off scores (>2 standard 
deviations). The RR-MS group had significantly higher scores on 
the measures of anxiety, depression and fatigue compared to HC. 
Cerebellar pathology was not correlated with any cognitive test. 
Imaging results found increased activity within the cerebellar 
cortex during the PASAT-3 in the RR-MS group compared to HC, 
despite no significant differences in scores. 
Rocca, 2012 
Case-
control 
with MRI 
To study whether 
cognitive failure on a 
neuropsychological 
test was associated 
with modifications of 
cerebellar-lobe 
connections. 
Type = RR-MS  
n = 17  
ratio = 71% 
age = 37.8 ± 9.9  
Edu = N/R  
Dur = 10 (2-18)  
EDSS = 2.0 (1-5) 
Type = HC 
n = 18  
ratio = 55%  
age = 43.9 ± 16  
Edu = NR  
Compared to HC, the RR-MS group demonstrated a different 
pattern of activation between the cerebellum and prefrontal 
regions during the Stroop paradigm. In RR-MS, superior cognitive 
performance was associated with activation of the cerebellum 
and the frontal gyrus. Furthermore, cognitive-related cerebellar 
activity was negatively correlated with disease duration. None of 
the RR-MS group were cognitively impaired. 
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Study 
Study 
Type 
Objective Case Group  Control Group Main Findings 
Romascano, 
2015 
Case-
Control 
with MRI 
The investigation of 
structural and 
functional integrity of 
cerebellar networks 
and relationship to 
clinical variables.  
Type = RR-MS 
n = 28  
ratio = 64%  
age = 34.32 ± 8.71 
Edu = 15.98 ± 2.78 
Dur = 25 (months) 
EDSS = 1.55 ± 0.21 
Type = HC 
n = 16 
ratio = 56% 
age = 33.06 ± 9.37 
Edu = 16.06 ± 3.51 
There were no differences in cognitive or motor performance 
between the two groups. There were no significant changes in 
the structural or functional properties of cerebellar networks in 
RR-MS in respect to HC. However, there were significant 
correlations between clinical performance, including measures of 
IPS, and subtle structural alterations, possibly indicative of MS 
pathology. 
Ruet, 2014 
Cohort 
design  
To study the 
relationship between 
cerebellar function as 
measured by motor 
testing and 
neuropsychological 
performance 
Type = RR-MS  
n = 60  
ratio = 82%  
age = 37.3 ± 9.9  
Edu = N/R  
Dur = 4.1 ± 3.0  
EDSS = 1.5 (0-4.5) 
No control group       
There were significant differences in performance on the NHPT 
and the Computerised-Speed-Cognitive test (CSCT, a measure of 
IPS) between RR-MSc (n = 11) and RR-MSnc (n = 48). For the 
whole sample, scores on the NHPT were correlated with CSCT, 
EDSS and disease duration, and exclusively correlated with IPS.  
Valentino, 2009 
Case-
Control 
To explore the 
relationship between 
cerebellar symptoms 
in RR-MS and 
neuropsychological 
features 
Type = RR-MSc  
n = 21  
ratio = 67%  
age = 37 ± 7.9  
Edu = 9.5 ± 3.3  
Dur = 9.8 ± 8.1  
EDSS = 2.5 (2-4)  
FSS = 4.35 (2-5.7) 
Type = RR-MSnc  
n = 21 
ratio = 67%  
age = 36.6 ± 7.9  
Edu = 11.2 ± 3  
Dur = 8.6 ± 5.2  
EDSS = 2 (1.5-4.5)  
FSS = 4.55 (1-6.4) 
In the initial sample of 111, approximately a third of RR-MS 
patients (31.5%) demonstrated evidence of cognitive 
impairment. When grouped according to cerebellar signs, 
patients with RR-MSc performed significantly lower on SDMT and 
COWAT tests when compared to individually matched RR-MSnc 
patients, performance was similar in other cognitive measures. 
Weier, 2014 
Cohort 
design 
with MRI 
Investigation of the 
relationship between 
cerebellar signs in MS 
and cognitive 
performance 
Type = RR-MSc*  
n = 50  
ratio = 80%  
age = 41.5 ± 10.1 
Edu = N/R 
Dur = 11.7 ± 6.2 
EDSS = 1.5 (0-7.5) 
Type = RR-MSnc*  
n = 72  
ratio = N/R  
age = 51 ± 9.9  
Edu = N/R  
Duration = 18.2 ± 
10 EDSS = 4 (1-7.5) 
Within a large cohort of patients with MS, patients with 
cerebellar signs performed worse on cognitive tests than those 
without signs. Subgroup analysis of patients with RR-MSc 
indicated that cerebellar pathology does not substantially 
contribute to development of fatigue, whereas it did partially 
predict performance on SDMT and PASAT-3.  
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Study 
Study 
Type 
Objective Case Group  Control Group Main Findings 
Weier, 2016 
Case-
Control 
with MRI 
Investigation of the 
relationship between 
cerebellar pathology 
and cognitive 
functioning in 
paediatric RR-MS 
Type = RR-MS  
n = 28  
ratio = 75%  
age = 16.3 ± 2.2  
Edu = 15.7 ± 2.1**  
Dur = 4.6 ± 3.3  
EDSS = 1.25 (0-4) 
Type = HC  
n = 33  
ratio = 79%  
age = 15.5 ± 2.7  
Edu = 15.8 ± 1.9** 
Although within acceptable norms, RR-MS patient cognitive 
performance was reduced relative to controls on all cognitive 
measures. Cerebellar volumes were not statistically different 
between groups, although posterior cerebellar volume and 
infratentorial lesion volume accounted for extra variance in 
vocabulary (WASI Vocabulary) and IPS (SDMT). Anterior 
cerebellar volume predicted performance in motor function 
(NHPT). Results supported involvement of cerebellum in 
cognitive functioning.  
Notes: Groups – Type of MS phenotype; Number (n) of patients; Ratio of % female; Mean age in years; Mean education in years; Mean disease duration in years unless 
specified; EDSS mean. 
Abbreviations: RR-MS, Relapsing-Remitting Multiple Sclerosis; RR-MSc, RR-MS with cerebellar damage; RR-MSnc, RR-MS without cerebellar damage; HC, Healthy 
Controls; EDSS, Expanded Disability Status Scale; FSS, Fatigue Severity Scale; N/R, Not Reported. 
* Group information provided for all MS phenotypes 
** Parental Education in years 
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2.6 Discussion 
2.6.1 Summary  
The present report used a systematic review to examine the contribution of the 
cerebellum to cognition and related factors in RR-MS using all available outcomes 
from studies meeting predetermined criteria. Examination of the data revealed 
evidence that the cerebellum predominately contributes to the cognitive domains of 
IPS and executive functioning as well as motor function in RR-MS. Furthermore, there 
was evidence to suggest cerebellar symptomatology may indicate a distinct clinical 
subtype of RR-MS, involving more severe and widespread cognitive impairment. There 
was nominal evidence that the cerebellum contributes to other cognitive domains or 
related variables such as mood and fatigue. However, due to the limited number of 
studies exploring other variables this does not preclude the cerebellar potentially 
having a role. A comprehensive review of study characteristics revealed substantial 
variability in patients included and outcome measures used despite recommended 
test batteries such as BICAMS (Langdon et al., 2012). Limitations of the project include 
the small number of eligible studies, methodological differences and a lack of follow-
up data. Overall, there was substantial evidence to support that the cerebellum 
contributes to cognitive performance, particularly regarding IPS. Although the 
intricacies of the cerebellar-related cognitive impairment remain elusive, it is likely to 
be underpinned by integrity of cortico-cerebellar loops.  
 
2.6.2 Validity of Findings 
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The findings of the systematic review support the view that the cerebellum 
contributes to cognitive performance in RR-MS, influencing the specific domains of IPS 
and executive functioning. This is in line with previous work that has considered the 
role of the cerebellum in MS (Sarica, Cerasa, & Quattrone, 2015; Weier et al., 2015). 
Furthermore, the results are also in accord with conclusions drawn from research into 
the impact of cerebellar lesions in other diseases such as stroke and CCAS (Koziol et 
al., 2014; Stoodley & Schmahmann, 2010). The review challenges the tradition dogma 
that the cerebellum is purely concerned with motor functions and demonstrates 
cerebellar function in RR-MS also plays an important role in cognition.  
Although the cerebellum plays a role in cognition it was difficult to ascertain the 
magnitude of influence in part due to the heterogeneity in case and control groups. 
For instance, the review included data from adult and adolescent populations with 
varying disease duration. In addition, it remained difficult to isolate the precise 
contribution of the cerebellum from other potentially confounding demographic and 
clinical factors that might have accounted for differences between the two proposed 
RR-MS phenotypes. For example, cognitive reserve, as measured by premorbid 
intelligence or years of education, has been found to protect against the progression 
of cognitive decline over a 5 year period (Benedict, Morrow, Weinstock-Guttman, 
Cookfair, & Schretlen, 2010). Only half of the studies included provided information 
regarding years of education, therefore, it questions whether results represent two 
discrete phenotypes, or merely differences in patient’s cognitive reserve. Arguably, 
there is a need to further delineate the cognitive profiles of RR-MSc and RR-MSnc 
before firmer conclusions can be drawn. 
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2.6.3 Evidence for a Typical Profile 
An objective of the review was to consider the suggestion that cerebellar signs in RR-
MS might be indicative of a distinct phenotype with a differential cognitive profile. 
Despite small numbers, there was a consistent pattern demonstrating cerebellar signs 
and cognitive dysfunction often occurred in parallel and cerebellar symptomatology 
was associated with more widespread and severe cognitive impairment. In many 
ways, the profile reflects the deficits observed in CCAS (Schmahmann & Sherman, 
1998; Schmahmann, 2004). Regarding focal cognitive domains, the literature suggests 
that the RR-MSc profile is typically characterised by reduced IPS and executive 
dysfunction. Evidence from studies that included a neuroimaging method also 
suggested a lower posterior cerebellar volume and a higher lesion load in the 
infratentorial region were associated with worse cognitive performance. 
Furthermore, there is a suggestion that cerebellar pathology results in altered 
connectivity to compensate for damage, which in turn, is associated with inefficiencies 
in cognition and global decline. The collective findings imply support for a differential 
cognitive profile in RR-MSc patients, although disparity continues to surround the 
potential mechanisms. 
 
 
2.6.4 Mechanisms of Cerebellar Involvement 
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A further aim of the review was to elucidate the potential mechanisms underlying the 
relationship between the cerebellum and cognition impairment. It appears there are 
three key mechanisms, not necessarily mutually exclusive, which might account for 
deficits: cerebellar atrophy and lesion; atrophy in associated cortical areas; or 
disrupted cortico-cerebellar connections. 
Certain studies indicated that cognitive impairment is predicted by cerebellar 
pathology. For example, Cirillo et al (2016) found a higher cerebellar lesion load in 
cognitively-impaired than in cognitively-preserved RR-MS paediatric patients. In 
addition, Demasceno et al (2014) found a higher burden of cerebellar intracortical and 
leukocortical lesions were associated with worse SDMT and PASAT scores 
respectively. This observation was also noted in studies by Weier et al (2014, 2016) 
whereby both cerebellar atrophy and lesion in RR-MS contributed to cognitive 
impairment in IPS. In contrast, research has also indicated that cognitive deficits might 
be more related to grey matter pathology in supratentorial regions. For instance, 
Cerasa et al. (2013) found that grey matter volume loss in the frontal and temporal 
cortical areas were significantly correlated with performance on the SDMT and 
COWAT respectively. Similarly, Weier et al (2016) concluded that diffuse pathology in 
other parts of the brain is likely to play a role in cognitive impairment independent of 
the cerebellum.  
Contrary to the above, there is also evidence that suggests neither cerebellar or 
cortical pathology significantly contributes to cognitive impairment. In the study by 
Valentino et al. (2009), total lesion loads in the four cortical lobes and the cerebellum 
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were compared with neuropsychological tests and no significant relationship was 
found. Additionally, Lesage et al. (2010) also found that cerebellar pathology was not 
correlated with any cognitive test. A recent study by Daams et al., (2016) which RR-
MS patients had a minimum disease duration of ten years, also found no relationship 
between cerebellar lesions and cognitive impairment. Instead, the authors concluded 
the strongest predictor of cognitive impairment was deep grey matter atrophy and 
diffuse white matter damage. Therefore, an alternative mechanism for cognitive 
impairment might be attributed to dysfunction in salient cortico-cerebellar 
connections. 
Neuroanatomical studies have demonstrated the existence of diverse connections 
between the cerebellum and the cerebral cortex that are organised into discrete 
‘loops’ to aid communication (Kelly & Strick, 2003; Middleton & Strick, 2000). A 
seminal consensus paper described the cerebellum as being critical for the modulation 
of sensorimotor and cognitive functions by way of these multiple cortico-cerebellar 
loops; controlling diverse streams of information underlying a wide range of functional 
domains (Koziol et al., 2014). It is considered that the presence of these functionally 
distinct cortico-cerebellar loops disencumber cortical regions by reducing the 
cognitive load, so that attention can focus on higher cognitive tasks such as motor 
planning or reasoning (Balsters et al., 2014; Stoodley, 2012). Thus, damage to loops is 
likely to compromise cognitive performance.  
Several of the studies included cite disrupted cortico-cerebellar connections as a 
further potential mechanism. For example, both Rocca et al. (2012) and Ruet et al. 
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(2014) suggest that cognitive impairment may be due to the employment of 
inefficient, compensatory loops because of MS-mediated damage to established, 
optimal cortico-cerebellar connections. This is demonstrated by Rocca et al. (2012) 
whereby superior cognitive performance on a task of executive function and 
information processing speed was associated with activation of the cerebellum and 
the frontal gyrus. Furthermore, Ceresa et al. (2012) observed poorer performance on 
another measure of information processing speed (PASAT) was associated with 
enhanced parietal lobe activation. Together, these results indicate that disruption to 
cortico-cerebellar loops might lead to costly inefficiencies and a saturation effect for 
cognitive load, resulting in cognitive deficits. Perhaps this also explains the presence 
of cognitive impairment even in the absence of significant correlations between 
neuropsychological outcomes in cerebellar pathology. 
Findings from the review imply there are correlations between cerebellar pathology, 
neuroanatomical connections and cognitive performance; namely information 
processing speed and executive functions. There are several mooted mechanisms 
thought to underlie the relationship and although the intricacies remain elusive, there 
is a consensus that the cerebellum forms part of salient cortico-cerebellar loops 
responsible for a range of both motor and cognitive functions, and if compromised, 
performance is adversely affected. To further understand the interrelation of 
cerebellar cognitive impairment, it is proposed that higher order cognitive functions 
such as motor planning, which are thought to be facilitated by cortico-cerebellar loops 
are explored (see Empirical Paper). 
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2.6.5 Significance of Work 
A move towards improved characterisation of MS heterogeneity has implications for 
increased understanding of pathophysiological mechanisms and development of 
tailored therapeutic interventions. The review indicates cerebellar symptomatology is 
indicative of a disease phenotype associated with more severe and widespread 
cognitive impairment. Thus, early intervention for MS individuals at increased risk of 
cognitive deficits provides an opportunity to optimise a differential rehabilitation 
approach. 
Cognitive remediation is the term used for interventions designed to mediate 
cognitive decline and can be typically identified as one of three different approaches: 
cognitive stimulation (CS), cognitive rehabilitation (CR) and cognitive training (CT). It 
has been proposed that participation in these mentally stimulating activities offers 
protection from neuropathology via a cognitive reserve (Sumowski, Chiaravalloti, 
Wylie, & Deluca, 2009). In part, the theory states that the higher an individual’s 
reserve which is measured by, educational attainment, leisure activity and occupation 
amongst other factors, the higher the threshold for any neuropathology to induce 
cognitive impairment (Stern, 2006).  
The efficacy of cognitive remediation in RR-MS has demonstrated benefits but also 
suffers from methodological concerns and limitations (das Nair, Martin, & Lincoln, 
2016; Goverover, Chiaravalloti, O’Brien, & DeLuca, 2018). For example, a home-based 
CT intervention improved performance on a measure of information processing speed 
(PASAT) and a memory task (CLVT-II, learning trials) but failed to include a follow-up 
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period to investigate whether benefits persisted (Hildebrandt et al., 2007). Another 
study investigating CT documented benefits across a range of cognitive domains in a 
group of individuals with objectively defined cognitive impairment (Pérez-Martín, 
González-Platas, Eguía-Del Río, Croissier-Elías, & Jiménez Sosa, 2017). However, the 
study pooled different phenotypes of MS, making it difficult to ascertain the 
magnitude of benefit for each MS group. 
The field of cognitive remediation provides an exciting opportunity to potentially delay 
or prevent cognitive impairment in MS. However, it has been hampered by limitations 
and may benefit from more rigorous methodological conditions such as clearer 
differentiation of individuals with RR-MS included and longer follow-up periods given 
the progressive nature of the disease. Thus, individuals with cerebellar 
symptomatology therefore represent a viable population to address some of these 
methodological issues and would allow for a more tailored rehabilitation approach. 
This has clinical implications for patients, researchers and medical teams. 
2.6.6 Future Directions 
Gold standard neuropsychological assessment was the main focus of evaluation in the 
studies included. Whilst this is a strength, future research should focus on the 
identification of pertinent outcome measures to detect changes that may otherwise 
be missed in standardised neuropsychological outcomes. For example, subjective daily 
functioning is fundamental to a sense of wellbeing in MS, yet few studies considered 
the contribution of cerebellar symptomatology to non-cognitive domains. It is 
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recommended that additional outcomes to evaluate everyday functioning, mood and 
quality of life are included. 
An increase in high quality randomly controlled trials, with increased sample sizes, and 
greater longitudinal follow-up data using an appropriate control group to control for 
non-specific effects is required. Rigorous participant selection using standardised 
diagnostic criteria should also be used to avoid pooling different MS phenotypes. 
Furthermore, the use of stringent criteria e.g. the use of North American Research 
Committee on MS Registry (NARCOMS) Tremor and Coordination Scale (TCS) (Marrie 
& Goldman, 2011) and neuroimaging techniques, should be used to clearly identify 
MS patients with cerebellar signs and provide a more accurate investigation of the 
influence of the cerebellum.  
To elucidate the intricacies of the cerebellar cognitive relationship it is recommended 
that novel measures of higher cognitive function such as motor planning are employed 
to substantiate developing theories as to how the cerebellar affects cognition (i.e. 
cortical-cerebellar loops). 
Finally, future studies should be equipped with a longitudinal component to provide a 
greater insight into the dynamics of cerebellar involvement in MS over time. Given the 
progressive nature of MS this would allow for longer periods of observation and 
address the lack of follow-up data in relation to long-term prognosis of cerebellum 
symptoms. 
2.6.7 Limitations 
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A drawback of the review was the relatively small amount of studies included. A 
comparable literature review of the contribution of grey matter to cognition in RR-MS 
included data from over 28 studies (van Munster, Jonkman, Weinstein, Uitdehaag, & 
Geurts, 2015). A synthesis of findings from an increased number of studies would lead 
to greater confidence in the conclusions deduced. Furthermore, as the field develops 
a meta-analysis and meta-regression could also be utilised to provide a more objective 
estimate of the evidence. 
One of the assumptions of the review was that all outcome measures within a specific 
domain shared homogeneity. It was beyond the scope of the review to discriminate 
between possible differences in outcome measures such as reliability or the 
underlying rationale. For example, both PASAT and SDMT are considered measures of 
IPS, although it has been argued that they rely on different neuroanatomical 
connections (Costa, Genova, DeLuca, & Chiaravalloti, 2017). In addition, performance 
on the PASAT is affected by mathematical ability (López-Góngora et al., 2015). To 
enable clearer interpretation of the results, it would have been useful to account for 
the variance between different outcomes, however no data on correlation between 
outcomes was available to allow this. 
Despite employing strict inclusion criteria, the review includes a heterogenous set of 
patients. For example, disease duration across studies ranged from a few months to 
over 10 years despite using widely accepted diagnostic criteria. This makes it difficult 
to ascertain whether there are meaningful differences between RR-MSc and RR-MSnc, 
or whether findings merely reflect a different stage of MS progression. For some 
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studies there was a lack of clear inclusion and exclusion criteria and other factors that 
might have accounted for deficits were not always considered. To illustrate, visual 
deficits are common in MS and research has found that visual-perceptual difficulties 
can reduce performance on neuropsychological tests (Feaster & Bruce, 2011). 
Therefore, these methodological concerns make it more challenging to assess the 
contribution of the cerebellum as large variability between study patients may mask 
true effects. 
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2.7 Conclusion 
The present systematic review has provided evidence that the cerebellum contributes 
to cognitive impairment in RR-MS patients. The evidence suggests the cognitive 
domains of IPS and executive function are the most susceptible to cerebellar damage. 
RR-MSc appear to be characterised by more severe and widespread damage, 
potentially representing a novel subtype of MS. The underlying mechanisms remain 
elusive; although, findings indicate the cerebellum forms part of salient cortico-
cerebellar networks responsible for a range of both motor and cognitive functions, 
and if compromised, performance is adversely affected. The review lends support to 
the hypothesis that the cerebellum underpins cognitive efficiency by disencumbering 
cortical regions through the reduction of cognitive load, so that attention can focus on 
higher cognitive tasks. The field would benefit from addressing methodological 
criticisms such as a lack of follow-up data and patient heterogeneity. To further 
understand the contribution of the cerebellum to cognitive performance it is 
recommended that a longitudinal study to investigate motor planning deficits by 
comparing patients with RR-MSc, RR-MSnc and HC is conducted. This has clinical 
implications regarding the management, understanding, and treatment of individuals 
with RR-MS. 
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3. The Relation of Cognition to Cerebellar Function in 
Relapsing-Remitting Multiple Sclerosis: A Longitudinal 
Study 
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3.1 Abstract 
Cerebellar signs and cognitive dysfunction often occur in parallel in Relapsing-
Remitting Multiple Sclerosis (RR-MS). Motor planning is thought to be one area of 
cognition susceptible to damage but also a surrogate of cerebellar integrity. 
Therefore, the objective was to investigate the longitudinal relation of cognition to 
cerebellar function in RR-MS and how changes relate to motor planning and function. 
A total of 11 RR-MS patients with cerebellar symptomatology (RR-MSc: 5 males, x ̅age: 
41), 17 RR-MS patients without cerebellar symptomatology (RR-MSnc: 2 males, x ̅age: 
40.94) and 9 matched control participants (HC: 2 males, x ̅age: 37.78) completed the 
Brief International Cognitive Assessment for MS (BICAMS), the Nine-hole Peg Test 
(NHPT) and the Grooved Pegboard Test (GPT) at baseline and at 12 months. The GPT 
- NHPT difference was used to compute a Motor Planning index (MPI), the NHPT 
serving as a control for sensorimotor impairment. 
Mixed ANOVA revealed a consistent significant group separation on all cognitive and 
motor tests other than visual memory that was maintained over the follow-up period. 
There was a significant effect of time for the visual and verbal memory suggestive of 
learning. There were no significant interactions between group and time. Post hoc 
tests showed the RR-MSc group was significantly outperformed in tests of cognition, 
motor function and motor planning by both RR-MSc and HC. There was a significant 
correlation between measures of information processing speed and MPI. 
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RR-MSc were characterised by greater impairment on tests of cognition, motor 
function and motor planning than the RR-MSc. These differences were maintained 
over a year. The association of the MPI and SDMT indicates information processing 
speed may act as a moderator of motor planning. The next step is to validate the MPI 
with an MRI study exploring how it relates to cerebellar lesion load and atrophy. 
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3.2 Introduction 
A key feature of Multiple Sclerosis (MS) is the marked variation of neurological 
symptoms, typically associated with lesions in eloquent areas of the central nervous 
system. One such area is the cerebellum which plays an important role in a range of 
functions (Koziol et al., 2014). Cerebellar damage in MS can lead to motor 
disturbances such as signs of tremor and loss of coordination (Weier et al., 2015). 
Cerebellar dysfunction is also associated with cognitive impairment. Research has 
shown the cognitive profile of patients with RR-MSc is characterised by more severe 
and widespread deficits, especially within the domains of information processing 
speed (IPS) and executive functioning (see Systematic Review). In MS, the presence of 
cerebellar signs and cognitive impairment have both independently been linked to 
poor prognosis and a considerable degree of disease-related impairment (Amato et 
al., 2010; Langdon, 2011; Langdon & Thompson, 1999; Weier et al., 2015). As such, it 
is vital that research efforts focus on developing a clearer measurement of the 
interrelation of cerebellar cognitive impairment. This has clinical implications for the 
management of MS as well as the potential to inform treatment development and 
offer more personalised medicine.  
3.2.1 Cognitive Impairment 
Cognitive impairment is a common and debilitating feature of MS with limited 
evidence of effective treatment (Goverover et al., 2018). Various factors have been 
shown to influence cognition including age, sex, educational attainment and mental 
health status (Benedict & Zivadinov, 2011; Goretti et al., 2014; Morrow et al., 2016; 
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Portaccio, 2016). As such, caution must be applied when attempting to disentangle 
cerebellar involvement in cognition against a background of potentially confounding 
variables. 
Research suggests there may be distinct clinical subtypes within RR-MS (Cerasa et al., 
2013; Valentino et al., 2009; Weier et al., 2014). The proposition of cognitive 
phenotypes within sub-types of MS patients is an emerging field yet appears to be key 
priority for future research. For example, a recent consensus paper recommended the 
identification of cognitive phenotypes in MS to facilitate greater understanding of 
cognitive deficits through the reduction in patient variability (Sumowski et al., 2018). 
Furthermore, the authors endorsed the use of prospective longitudinal designs to 
monitor changes in cognitive ability. Therefore, the use of cognitive phenotypes 
represents a viable opportunity to yield an increased understanding of mechanisms 
underpinning cognitive deficits and could provide important prognostic and treatment 
planning considerations. 
3.2.2 Cerebellum Function 
The cerebellum is acknowledged to have a role beyond purely motor control. 
Pioneering neuroimaging research has demonstrated the cerebellum contributes to a 
multitude of functions (Buckner, 2013). To illustrate, one study used a functional 
magnetic resonance imaging (MRI) paradigm to document the presence of distinct 
connections or ‘loops’ between the cerebellar and cortical regions during various tasks 
(Stoodley, Valera, & Schmahmann, 2012). It was concluded that cognitive tasks 
activated specific regions of the cerebellum separate from motor tasks. Further 
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evidence has been demonstrated in neuronal tracing studies and cerebellum 
functional topography (Kelly & Strick, 2003; Middleton & Strick, 2000; Stoodley & 
Schmahmann, 2009). Thus, there is compelling evidence to document the relationship 
between the cerebellar and areas of the cerebral cortex known to be important for 
cognition. 
Clinical studies of cerebellar damage have also demonstrated a role in cognition. In 
particular, the ‘cerebellar cognitive affective syndrome’ (CCAS) (Schmahmann & 
Sherman, 1998) is a condition that follows acquired lesions in the cerebellum. 
Sequalae include executive dysfunction, impaired working memory, visuospatial 
deficits as well as personality and affect changes. Additionally, damage to the integrity 
of cortico-cerebellar loops in MS has been linked with worse performance on several 
cognitive outcome measures (Cerasa et al., 2013; Valentino et al., 2009; Weier et al., 
2014). However, despite research demonstrating an important role for the cerebellum 
in cognition, it remains unclear how the cerebellum participates in cognition. 
3.2.3 Cerebellum and Motor Control 
Although there is no clear consensus as to how the cerebellum contributes to motor 
control (Manto et al., 2012), one theory of interest is that of internal models used to 
emulate movement through the creation of subroutines. An internal model is a neural 
representation of the external world that can be generated and stored within the 
cerebellum (Ito, 2012). The model postulates that the cerebellum has the ability to 
encode an internal model through repeated performance and sensory feedback (Ito, 
2008). Accordingly, during tasks such as upper arm movement the cerebellum can 
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develop and hold a representation of information developed in the motor cortex 
during motor learning as a subroutine. This subsequently acts as a template or 
‘shortcut’ that can be used to perform precise movement without external feedback 
or even conscious awareness.  
Support for the model is arguably demonstrated in the Nine-hole Peg Test (NHPT), a 
measure for assessing upper limb function, whereby superior performance, in part, is 
dependent on cerebellum integrity. MS patients with cerebellar damage have been 
found to perform worse on the NHPT compared to controls without cerebellar signs 
(Romascano et al., 2015; van de Pavert et al., 2016; Weier et al., 2014). It is implied 
that damage to the cerebellum somehow disrupts the subroutine required for precise 
action and consequently impairs task performance. However, one caveat is that 
disruption can also be attributed to more general sensorimotor deficits. 
A proposed consequence of cerebellar dysfunction is the loss of efficiency. The 
‘Universal Cerebellum Transform’ model argues that the cerebellum acts as a 
moderator for controlling diverse streams of information by way of multiple cortico-
cerebellar loops (Koziol et al., 2014). It is assumed that the cerebellum functions by 
optimising task performance. Accordingly, as the cerebellum develops a subroutine, a 
specific task becomes more automatic and the corresponding cortical regions are 
freed to engage in other tasks. This results in an overall increase in task efficiency 
through optimal performance. In contrast, the loss of these subroutines through 
cerebellar damage results in greater attention being given to previously more 
automated, less conscious processes and a loss in efficiency. This process is named, 
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‘Universal Cerebellar Impairment’, and is thought to underpin motor and cognitive 
deficits (Guell, Gabrieli, & Schmahmann, 2018). 
3.2.4 Cerebellum and Cognition 
It has been proposed that the mechanisms underlying the role of the cerebellum in 
motor control can also be applied to cognitive functions (Guell et al., 2018; Koziol et 
al., 2014). Similar processes are considered to support the precise execution of mental 
acts. For example, cerebellar damage has been associated with a loss of precision and 
efficiency of linguistic abilities and impairment of higher-order cognitive processes 
typically associated with frontal regions (Guell, Hoche, & Schmahmann, 2015; 
Schmahmann & Sherman, 1998). Thus, cognitive impairment in MS may be associated 
with damage of automated subroutines, and a subsequent loss of efficiency. 
Several neuroimaging studies have demonstrated cerebellar damage in MS results in 
the recruitment of inefficient compensatory networks (Bonnet et al., 2010; Moroso et 
al., 2017; M. Rocca et al., 2012, 2017). Bonnet et al (2010) concluded that the 
abnormal pattern of connectivity is based on ‘cognitive compensation failure’. The 
authors state that cerebellar damage results in an inability to use automated cognitive 
processes (i.e. subroutines) and leads to compensatory recruitment of cortical regions 
usually preserved for higher-order cognitive tasks. Although this compensation might 
mediate the loss of cognitive ability, it is likely this also contributes to a reduction in 
cognitive efficiency. Therefore, it is hypothesised that the cerebellum functions as a 
strategic node in various networks with multiple connections; dysfunction caused by 
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MS pathology is likely to disrupt optimal functioning. This results in a loss of efficiency 
in motor and cognitive tasks as the cerebellum mediates both. 
3.2.5 Motor Planning 
Further research is required to substantiate the hypothesis that the cerebellum 
contributes to cognition in MS using subroutines. Motor planning is a cognitive ability 
often associated with the frontal lobe and seen as the ability to conceive, plan and 
execute coordinated motor responses (Kemenoff, Miller, & Kramer, 2002). Based on 
the internal model theory, optimal performance in motor planning is likely to be 
dependent on cerebellum integrity and therefore it serves as a useful indicator of 
cerebellar function. It is possible that there may be a relationship between motor 
planning deficits and a reduction in IPS due to the inefficient compensatory 
recruitment of cortical areas instead of being able to use subroutines to aid 
performance (Bonnet et al., 2010). Therefore, the recruitment of RR-MSc patients and 
comparing performance on motor planning and cognitive tasks with RR-MSnc and 
healthy controls (HC) offers an opportunity to further elucidate cerebellum 
involvement in cognition. 
To calibrate cerebellar function, a novel measure of motor planning is required. Upper 
limb function is considered an important driver of disability in MS (Lamers & Feys, 
2014). In addition, grassroots campaigns (e.g. #ThinkHand on social media) have made 
calls for greater emphasis on the contribution of upper limb impairment. Taking this 
into consideration and given MS involves physical symptoms and restrictions on 
sensorimotor function, which might confound motor planning requirements in 
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standardised upper limb outcome measures, a Motor Planning Index (MPI) will be 
utilised (see Method 3.4.6).  
3.2.6 Summary 
Cognitive impairment affects a significant proportion of people with MS. It has been 
proposed that the cerebellum forms part of salient cortico-cerebellar loops 
responsible for intact cognitive functioning. The cerebellum is thought to optimise 
task performance through automated templates called subroutines. Damage to the 
cerebellum leads to inefficiencies in motor and cognitive function through the 
disruptions of subroutines and the forced employment of compensatory networks. 
Motor planning is a higher-order cognitive ability and considered to be a measure of 
cerebellar integrity. Thus, it is likely that inefficiencies of motor planning will be 
associated with cognitive decline, particularly IPS, as the cerebellum mediates both. 
There is an opportunity to further elucidate cerebellum involvement in cognitive 
impairment by investigating how cerebellar damage in MS underpins motor planning, 
and whether this relates to cognitive function. 
3.3 Outline of the Research: Objectives and Rationale 
The study builds on earlier cross-sectional study investigating cognition and motor 
planning in MS by adding a longitudinal component to offer greater insight into 
disease-related cognitive change. Data from the previous study by Hinchcliffe (2017) 
will be combined with the present study to address the research questions (see 3.3.1). 
 74 
 
 
The proposed study aims to explore the longitudinal relation of cognition to cerebellar 
function in RR-MS. The study focuses on three areas of inquiry: (i) whether cognitive 
deficits at baseline remain stable over the course of a year; (ii) calibrating motor 
planning and upper limb function changes over the year; and, (iii) whether differences 
in motor planning between MS subtypes and healthy controls are related to IPS given 
the hypothesised role of the cerebellum increasing task efficiency. The study has 
several clinical implications such as modified rehabilitation pathways, as well as a 
potentially providing a precise measure of cerebellar function via a novel measure of 
motor planning. 
Given the progressive nature of MS it is important to have longer periods of 
observation. There are currently no longitudinal studies examining the 
aforementioned relationship over time. Therefore, the research is justified given the 
lack of longitudinal studies in the area and the ability to detect cognitive changes in 
MS over relatively short follow-up periods (López-Góngora et al., 2015; Weier et al., 
2015). The research also aligns with wider NHS research policy recommending 
increased focus on understanding cognitive impairment in MS (NICE, 2014), and the 
use of cognitive phenotypes to offer a more precise estimate of impairment 
(Sumowski et al., 2018). Finally, grassroots campaigns involving social media (e.g. 
Burke, 2018) and a comprehensive review of assessment tools for upper extremity 
function have emphasised the need for research to consider the contribution of upper 
limb functional impairment (Kraft et al., 2014). Therefore, the battery has been 
amended to include a patient reported outcome measure of upper limb function 
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which will enable a synthesis of objective and subjective motor function and thus 
enhance understanding of upper extremity function in MS. 
Therefore, the study will re-assess participants from the three groups: RR-MSc, RR-
MSnc and healthy controls (HC) after 1-year and compare results to baseline. 
3.3.1 Hypotheses 
(i) The baseline finding that patients with RR-MSc have a differential 
cognitive profile to RR-MSnc and HC, demonstrated by worse 
performances on tests of IPS, memory and verbal fluency will be 
replicated at 1-year follow-up. 
(ii) The performance of patients with RR-MSc on cognitive and motor 
planning tasks will decline over a 1-year period compared to patients 
with RR-MSnc and HC, who in turn, will remain stable. 
(iii) Differences in motor planning will be related to differences in 
information processing speed at 1-year follow-up. 
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3.4 Method 
3.4.1 Research Approval 
The study protocol was approved following a favourable ethical review from the NHS 
Health Research Authority (See Appendix 1). Subsequently, the Research and 
Development (R&D) department in a Surrey NHS Foundation Trust gave permission 
for the recruitment of MS participants (See Appendix 2). Ethical approval was then 
obtained from the research ethics committee at Royal Holloway, University of London. 
3.4.2 Participants 
Between December 2017 and April 2018, a total of 28 RR-MS patients and 9 control 
participants were recruited for the follow-up study. The number and reason for drop-
outs are described in Results section 3.5.2. MS patients were previously allocated into 
RR-MSnc or RR-MSc based on the North American Research Committee on MS 
Registry (NARCOMS) Tremor and Coordination Scale (TCS) (Marrie & Goldman, 2011). 
The total number of participants who completed the study were as follows: RR-MSnc 
17/21 (two males, a mean age of 41 and a mean premorbid IQ of 106.7); RR-MSc 11/14 
(five males, a mean age of 41 and a mean premorbid IQ of 100.9); HC 9/28 (2 males, a 
mean age of 37.8 and a mean premorbid IQ of 107.0).  
3.4.3 Recruitment 
MS participants were restricted to those previously recruited from NHS Foundation 
Trusts in Surrey and Wandsworth. Permission to be contacted by the researcher was 
sought via a letter sent by the clinical team. Upon contact, a participant information 
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sheet (see Appendix 3) was sent via email and a home visit arranged to gain written 
informed consent (See Appendix 4) and for data collection. Participants with MS were 
previously known to the research team; thus, home visits were deemed safe and 
appropriate. An invitation letter was sent to individuals whom requested it (see 
Appendix 5). Participants were told that they were able to decline participation in the 
follow-up study and free to withdraw at any time, without giving a reason, and that 
this would not affect their clinical care or legal rights. 
As mentioned, participants were previously allocated to RR-MSnc or RR-MSc based on 
the NARCOMS-TACS, a validated self-report measure of cerebellar involvement. 
Participants were allocated to the RR-MSc group if they scored four or five out of a 
possible five on the NARCOMS-TACS indicating at least ‘severe tremor or loss of co-
ordination’. The scale was again administered at follow-up to ascertain whether any 
changes had occurred during the follow-up period. 
For controls, an invitation letter (See Appendix 6) was sent along with a participant 
information sheet (See Appendix 7). All participants contacted the researcher if they 
wished to be involved, and an appointment was arranged to gain written informed 
consent (see Appendix 8). All HC were assessed in the researcher’s home and informed 
participation was voluntary and they were entitled to withdraw at any time without 
giving a reason. 
 
3.4.4 Inclusion and Exclusion Criteria 
 78 
 
 
All participants were fluent English speakers, whose first language was English and 
aged between 18-60 at baseline. Specific inclusion criteria for MS groups at baseline 
assessment were twofold: a clinically definite RR-MS based on Polman et al., (2011) 
or equivalent; and an Expanded Disability Status Scale, telephone version (EDSS) score 
from 0 – 5 (Lechner-Scott et al., 2003). If a RR-MS participant no longer met inclusion 
criteria due to disease progression (e.g. EDSS >5), data were still collected and 
analysed.  
Exclusion criteria for all participants included: a diagnosis of psychiatric illness, 
substance misuse disorders, epilepsy or head injury; significant visual, motor, or 
hearing impairments which would deny full engagement in cognitive tests; or, a lack 
of capacity to consent.  
3.4.5 Power Analysis 
A mixed analysis of variance (ANOVA) was selected due to the combination of 
between- and within-subject factors. The number of participants required to be 
retained was calculated using G*Power (Faul, Erdfelder, Lang, & Buchner, 2007).  
The Symbol Digit Modalities Test (SDMT) is considered one of the most reliable and 
sensitive neuropsychological tests for MS (Benedict et al., 2017). The mean effect size 
using Cohen’s d (Cohen, 1992) for MS and HC comparisons has been established as d 
= 1.11 (Benedict et al., 2017). Therefore, a large effect size of d = 1.1 was utilised for 
the power analysis.  
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The power calculation for a mixed design ANOVA using the following: α = .05, power 
= .8, effect size (d) = 1.1, group number = 3, measures = 8 and correlation between 
repeated variables conservatively estimated at 0.5 indicated that 11 participants per 
group were required, a total of 33 participants for an actual power = .96. 
3.4.6 Materials 
The test battery consisted of questionnaires, neuropsychological tests and peg tests 
designed to provide a comprehensive measure of cognitive, motor and cerebellum 
functioning. The battery was selected based on best available evidence, whilst 
considering the effects of fatigue on performance. Standardised test instructions were 
adhered to so to allow comparisons to baseline performance and to published norms. 
Testing was completed over the course of a single session with breaks if required and 
efforts to reduce potential distractions within the immediate vicinity made. 
Competency in the delivering of the test battery was assessed by a Professor in 
Neuropsychology. The test battery was amended from baseline to include a measure 
of visual acuity and a patient reported outcome measure of upper limb function.  
(a) Questionnaires 
Expanded Disability Status Scale (EDSS) Telephone Version - Lechner-Scott et al., 
(2003): A telephone adapted version of the EDSS to provide a quantitative overall 
measure of disability in MS (see Appendix 9). Scores on the EDSS range from 0 (no 
disability) to 10 (death due to MS) using 0.5 increments. The telephone version has 
been demonstrated to have a robust correlation with the physician-led physical 
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examination (r = .95) (ibid). Psychometric properties for the EDSS have demonstrated 
concurrent validity in RR-MS with neuroimaging markers (Kalkers et al., 2001), good 
internal consistency (α ≤ .96) and test-retest reliability (r = .87) (Schäffler et al., 2013). 
The EDSS remains the most widely used outcome measure for disability progression 
in MS. 
In the present study, MS participants were attributed a score either based on 
impairment to walking (EDSS 5.0 – 9.0) or via functional system (FS) scores including: 
vision, brainstem, pyramidal, cerebellar, sensory, bowel and bladder, and cerebral 
functional systems (EDSS 4.5 – 1.0). The single worse score in each FS subsection 
determined the FS score which was then used in conjunction with FS frequency tables 
to determine an EDSS score. Permission was granted from Professor Ludwig Kappos 
(senior author of Lechner-Scott et al., 2003) to utilise the English version. 
Tremor and Coordination Scale (TCS), NARCOMS - Marrie & Goldman (2011): A single 
response questionnaire-based measure comparing both frequency and impact of 
tremor and/or co-ordination to experience before developing MS (see Appendix 10). 
Scores on the TCS range from 0 (minimal tremor or loss of coordination) to 5 (total 
disabling tremor or loss of coordination). Psychometric properties for the NARCOMS-
TCS has shown adequate construct validity and criterion validity for those with an 
EDSS of 0 - 6.5 with moderate Spearman’s rank correlations with the cerebellar 
functional system score (r = .51) and the Nine-hole Peg Test (r = -0.51) (Marrie & 
Goldman, 2011).  
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The Fatigue Severity Scale (FSS) - Krupp, LaRocca, Muir-Nash, & Steinberg (1989): A 
subjective measure of fatigue with the ability to discriminate between depression and 
fatigue (see Appendix 11). It has 9 statements and respondents rate how much they 
endorse these from 1 (strongly disagree) – 7 (strongly agree), and a mean response is 
calculated. Psychometric properties of the FSS have reported strong internal 
consistency for MS populations (α = .81) and test-retest reliability (Krupp et al., 1989). 
Construct validity (r = 0.74) was demonstrated when compared to the Modified 
Fatigue Impact Scale (MFIS) (Amtmann et al., 2012).  
The Hospital Anxiety and Depression scale (HADS) - Zigmond & Snaith (1983): A 14-
item scale with seven statements measuring anxiety (HADS-A) and seven statements 
measuring depression (HADS-D) (see Appendix 12). Each item is rated 0 – 3, with 
higher ratings pertaining to higher symptom severity. The range of the HADS-A and 
HADS-D is 0 – 21 with cut-off scores 0 – 7 (normal range), 8 – 10 (mild range), 11 – 14 
(moderate range) and 15 – 21 (severe range). The psychometric properties for the 
HADS have recently been studied in relation to several other mood screening tools in 
MS (Marrie et al., 2018). For HADS-D and HADS-A, specificity (95% and 86%) was 
generally higher than sensitivity (31% and 64%) but provided superior estimates of 
depression and anxiety over other tools. Both the HADS-D (α = 0.82) and HADS-A (α = 
0.86) demonstrated acceptable internal consistency reliability. 
ABILHAND - A self-report measure of manual ability – Penta, Thonnard, & Tesio 
(1998). A 26-item measure of manual ability for adults with upper limb impairments 
(see Appendix 13). The scale measures patient-perceived difficulties in performing 
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activities of daily living. The measure has been validated in MS and reliability found to 
be high (Barrett, Cano, Zajicek, & Hobart, 2013). 
(b) Cognitive Tests 
The cognitive battery includes the three tests (SDMT, BVMT-R learning trials and CVLT-
II learning trials – see below) from the Brief International Cognitive Assessment for 
Multiple Sclerosis (BICAMS; Langdon et al., 2012) as well as a two tests (WLG and 
PASAT-3) which form part of the Brief Repeatable Battery of Neuropsychological Tests 
(BRB-N; Boringa et al., 2001). Each test has been demonstrated to be sensitive to 
measuring cognitive impairment in MS, with BICAMS considered the gold standard for 
cognitive screening in MS. The battery also included a test of predicted intelligence 
(PFSIQ) to ensure the groups are matched for premorbid IQ function and a visual 
acuity measure to ensure visuo-perceptual difficulties cannot account for test 
performance. 
Test of Premorbid Functioning (TOPF) – Wechsler (2011): The TOPF is a brief test to 
predict premorbid intelligence (IQ) (see Appendix 14). It consists of 70 words with 
abnormal grapheme/phoneme translations. Participants read the list aloud, and the 
number of phonetically correct words spoken provides a score. The raw score is 
combined with demographic information including age, sex and years of education to 
compute a predicted full-scale IQ (PFSIQ). The test was used to ensure groups were 
matched for premorbid function that might otherwise influence performance. 
Psychometric properties for the TOPF are well established, there is good test re-test 
reliability (r = .89 to .95) and high split-half reliability (r = .92 to r = .99) (Wechsler, 
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2011). It also demonstrates concurrent validity with the WAIS-IV verbal 
comprehension index (r = .75), processing speed index (r = .37) (Wechsler, 2011). 
Symbol Digit Modalities Test (SDMT) – Smith, 1982: A test of IPS whereby symbols 
are paired with numbers (see Appendix 15). Following a practice phase, individuals are 
required to orally state the numbers that correspond to figures presented. The total 
score is the number of correct responses within a 90-second limit. The SDMT is the 
most commonly used test in standard MS batteries due to the ease of administration, 
accessibility and excellent psychometric properties (Benedict et al., 2017). The SDMT 
demonstrates good  test–retest reliability (r = 0.97) in MS (Benedict, 2005), 
demonstrated the largest effect size (d = 1.1) amongst a number neuropsychological 
tests in discriminating between MS and control groups (Benedict et al., 2006) and has 
good construct validity in MS as it is strongly associated with neuroimaging disease 
markers (Christodoulou et al., 2003). 
Word List Generation (WLG) Version A: The WLG is a 90-second test of semantic 
fluency naming as many words within a given category (see Appendix 16). The 
category was ‘fruits and vegetables’. The total score is the number of words stated 
fitting the category.  Psychometric properties include a sensitivity of 82% and 
specificity 66% in discriminating cognitive impairment in syndromes suggestive of MS 
when using a cut-off of <28 (Viterbo, Iaffaldano, & Trojano, 2013). Good construct 
validity has been demonstrated with neuroimaging markers of atrophy (Morrow, 
Menon, Rosehart, & Sharma, 2017). 
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Paced Auditory Serial Addition Test (PASAT) - Gronwall and Sampson, 1974: This is a 
test of IPS and sustained and divided attention as well as working memory and 
calculating speed (see Appendix 17). The examiner presents numbers every three 
seconds (recorded for standardisation), and the participant must add this number to 
the previous number presented. The total score is the correct number of responses. 
The PASAT-3 was preferred to the PASAT-2, whereby numbers are presented every 
two seconds, for participant tolerability and to enable direct comparisons to baseline 
performance. Psychometric properties have shown the PASAT-3 to have good inter-
rater reliability (r = .90 to .97) and test-retest reliability good test-retest reliability (r = 
.92) (Solari, Radice, Manneschi, Motti, & Montanari, 2005) and reported a sensitivity 
of 73% and specificity of 59% for cognitive impairment (López-Góngora et al., 2015). 
California Verbal Learning Task (CVLT-II) – Woods, Delis, Scott, Kramer, & Holdnack 
(2006): A measure of verbal learning and memory (see Appendix 18). The CVLT-II 
learning trial involves a list of 16 words split into four categories. The experimenter 
reads all words (<1 word/second), and the participant recalls as many words as 
possible. The score is the total number of words recalled over five trials. The CVLT-II 
involves several trials yet only the learning trial was included to reduce the number of 
cognitive processes involved (Langdon et al., 2012). Psychometric properties were 
therefore inferential. The test has demonstrated good internal consistency (α = .83 to 
.96) and test-retest reliability in MS populations (Woods et al., 2006). Construct 
validity within the MS population to employment status has also been demonstrated 
(Stegen et al., 2010). 
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Brief Visual Memory Test – Revised (BVMT-R) – Benedict, Schretlen, Groninger, 
Dobraski, & Shpritz (1996): A test of visual learning and memory (see Appendix 19). 
Participants are presented with a set of 2x3 geometric figures for 10 seconds. 
Following removal of the stimulus sheet, participants are required to draw these 
shapes in the same position as the stimulus sheet. A point is awarded for accurate 
drawing and correct location with a maximum score of 36 over three trials. The BVMT-
R incorporates other trials, yet only the learning trials were included for similar 
reasons to the CVLT-II. Thus, inferred psychometric properties demonstrate good 
inter-rater reliability (r > .90), and good test-retest reliability (r = .80) (Benedict, 1996). 
It has been demonstrated to be sensitive to impairment with MS populations 
(Benedict et al., 2001; Langdon et al., 2012) and construct validity shown through 
associations with neuroimaging disease markers (Benedict et al., 2001; Langdon et al., 
2012). 
Snellen Pocket Visual Acuity Test – Snellen, 1862. This standardised test examines the 
ability to discriminate high contrast fine detail at a distance; the acuity of vision (see 
Appendix 20). The pocket version has been adapted for testing at 12 – 14 inches. A 
score was recorded for the smallest line of letters which were all correctly read. A cut-
off score based the logMAR scale of >0.5 (defined as ‘moderate’ visual impairment; 
Colenbrander, 2002) was inferred as a marker of impaired visual acuity and thus likely 
to impair neuropsychological performance (Colenbrander, 2002).  
(c) Peg Tests 
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Nine-hole peg test (NHPT) – Mathiowetz, Weber, Kashman & Volland, 1985: This 
provides a quantification of upper limb motor function and physical disability (see 
Appendix 21). Participants are required to pick up pegs, one at a time, and fill the holes 
in any order on a board before returning them, one at a time, to the container. The 
test is repeated twice with both hands and a mean time across trials is used to provide 
a score. Important psychometric properties have illustrated high inter-rater (r = .84 - 
.96) (Feys et al., 2017; Solari et al., 2005), internal consistency (α = .93) (Rasova, 
Martinkova, Vyskotova, & Sedova, 2012), and reduced performance is indicative of 
cerebellar atrophy (Ruet et al., 2014; van de Pavert et al., 2016).  
Grooved Pegboard Test (GPT) – Trites (1989): The test consists of a pegboard with 25 
holes (see Appendix 22). Boat-shaped pegs must be inserted into randomly positioned 
holes in the correct orientation sequentially from the opposite side of the board to 
the hand that they are using. The first row is demonstrated before the participant 
completes the remaining holes. Each hand is tested before a mean time is used to 
provide a score. In comparison to the NHPT, the GPT requires more motor planning 
and co-ordination. Psychometric properties for the GPT indicate variable test-retest 
reliability within healthy controls (r = .67 to .86) (Levine, Miller, Becker, Selnes, & 
Cohen, 2004; Ruff & Parker, 1993) and a weak/modest association with activities of 
daily living and GPT scores in MS (Kessler, Cohen, Lauer, & Kausch, 1991). 
Motor Planning Index (MPI): To calibrate a measure of motor planning, a MPI score 
was calculated by subtracting the NPHT from the GPT. The rationale underlying the 
MPI is based on subtraction logic to isolate a critical component and often used in MS 
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research (Roth, Denney, & Lynch, 2015; Shoben, Cech, & Schwanenflugel, 1983).  It is 
assumed that the GPT has a greater motor planning component than the NHPT, but 
both have a sensorimotor component. By subtracting the time taken on the NHPT 
from the GPT, we have an indication of motor planning whilst controlling for 
sensorimotor function. 
3.4.7 Design and Procedure 
The design was based on an earlier study by a previous DClinPsy trainee investigating 
how the cognitive profile of  RR-MSc related to motor planning and motor function, 
and how this differed from RR-MSnc and HC (Hinchliffe, 2017). A total of 56 
participants completed the test battery and statistical analysis revealed the RR-MSc 
group showed greater impairment than RR-MSnc on cognitive tests and motor tasks. 
Therefore, the present design involved a repeat test battery of questionnaires, 
neuropsychological tests and two peg board tests to all participants at 1-year follow-
up. Each participant had previously been allocated an anonymised participant 
identification number which was used to amalgamate baseline and follow-up data. 
Name and identification number pairings were kept in separate encrypted and 
password-protected spreadsheets.  
The battery was identical to the baseline assessment with the additional of two tests 
(ABILHAND and Snellen Pocket Eye Test) and was administered in same order except 
for the additional tests which were added into the schedule before the start of the 
cognitive tests to minimise interference. Home visits were completed in accordance 
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to the Camden and Islington NHS Foundation Trust Lone Working Policy (September 
2015). 
Upon arrival at the testing location, each participant was provided with an oral agenda 
of the assessment and informed that the test battery would take an estimated time 
of 60 minutes. Participants were provided the opportunity to ask specific questions 
before written informed consent was gained and they were advised of their ethical 
and legal rights. 
During a short clinical interview, demographic information (gender, age, and 
educational level) and time since diagnosis was cross-referenced with information 
collected at baseline. Participants were then asked about changes in medication and 
whether they had experienced a relapse within the last two months. All data were 
recorded on paper before transferred to an electronic spreadsheet which was 
encrypted and password-protected. Next, all questionnaires were administered 
before participants completed the test battery in the order demonstrated in Table 6 
and in accordance with their baseline randomisation number to dictate the order of 
the peg board tests.  
 
 
Table 6 Questionnaire, cognitive test and pegboard administration order 
Procedure Tests administered (in order) 
Questionnaires 1. EDSS Telephone Version 
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 2. NARCOMS-TACS 
 3. FSS 
 4. HADS 
 5. ABILHAND 
 6. Snellen Pocket Eye Test 
Pegboard Test 1 7. NHPT/GPT* 
Cognitive Tests 8. TOPF 
 9. SDMT 
 10. CVLT-II Learning Trials 
 11. BVMT-R Learning Trials 
Pegboard Test 2 12. NHPT/GPT* 
Cognitive Tests 13. WLG 
 14. PASAT-3 
*Order established by counterbalancing  
 
3.4.8 Analysis 
The Statistical Package for the Social Sciences 21.0 (SPSS) was utilised to analyse data 
(IBM Corp., 2013). All variables were subject to exploratory data analysis to assess 
whether assumptions for parametric analysis were met. Variables were subject to 
transformations if data at either baseline or follow-up was found to have a non-normal 
distribution. 
Only participants with a full dataset were included in the main analysis. No 
participants were excluded. Successful matching of participants between groups with 
regards to pre-morbid intelligence, depression, anxiety, fatigue, EDSS and age was 
checked using a one-way between-subjects ANOVA. A mixed design ANOVA was 
utilised to make comparisons of RR-MSnc, RR-MSnc and HC (Group factor) on 
neuropsychological and pegboard test means between baseline and follow-up (Time 
factor). To investigate the relationship between objective motor function (NHPT and 
GPT) and subjective motor function (ABILHAND), a Pearson’s correlation (r) analysis 
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and correlation coefficients were calculated. Finally, to examine the strength of the 
relationship between MPI and measures of IPS, data was subjected to Pearson’s 
correlation (r) analysis and correlation coefficients calculated when significant 
correlations were present.  
Post hoc adjustments were considered to protect the family-wise error rate. However, 
due to the number of multiple comparisons within the battery and to prevent utilising 
a too stringent corrected p-value (e.g. Bonferroni), and thus greater likelihood of 
rejecting a meaningful difference (Field, 2009) (type II error), Least Significant 
Difference (LSD) values (equivalent to no adjustments) were utilised to clarify 
significant findings. If group variances were found to be non-equivalent, Games-
Howell comparisons were used instead.  
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3.5 Results 
3.5.1 Exploratory Data Analysis 
A prerequisite for parametric tests is the assumption of a normal distribution; 
therefore, a cut-off of ±2.58 (p < .01) for skewness and kurtosis was utilised to check 
the distribution of scores (Field, 2011). For baseline data, converted z-scores revealed 
MPI for the RR-MSnc group was positively skewed. In addition, for follow-up data 
ABILHAND data was negatively skewed for the RR-MSnc group and NHPT was 
positively skewed for the RR-MSc group. For all other data, skewness and kurtosis fell 
below ±2.58, thereby meeting normality assumptions for parametric tests (p < .01) 
(See Appendix 23 & 24) 
Field (2011) recommends using a reverse score, square-root transformation for 
negatively skewed data. The ABILHAND was significantly negatively skewed for the RR-
MSnc group (z = -2.75, p<.01).  After subtracting the highest score + 1, a square root 
transformation was carried out, which resulted in the data being normally distributed 
(z = -1.49, p<0.1). Furthermore, Tabachnick and Fidell (2013) recommend a logarithmic 
transformation (Log10) for substantially positively skewed data. As the MPI for the RR-
MSnc group (z = 2.90, p<0.1) at baseline and the NHPT for the RR-MSc group (z= 3.13, 
p <0.1) at follow-up were both highly positively skewed, a Log10 transformation was 
applied to achieve a normal distribution (MPI: z = 1.83, p <0.1; NHPT: z = 2.13, p<0.1) 
(See Appendix 25) 
According to Field (2011), to compare differences between variables (e.g. change in a 
variable over time), the same transformation must be applied. Therefore, variables 
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that were transformed at either baseline or follow-up had corresponding data 
transformed to facilitate comparisons. 
3.5.2 Baseline demographics 
An overview of the descriptive statistics for demographic information at baseline for 
participants who completed and dropped out are presented in Table 7. There were no 
significant differences for age (F(2,34) = .41, p = .665), years of education  (F(2,34) = 
2.44, p = .103) or predicted full-scale IQ  (F(2,34) = 1.44, p = .251) between the groups. 
For disease duration, separate variance estimates were used as homogeneity of 
variance was not met (F = 5.96, p = .022). Although non-significant, RR-MSc had 
trending significance for a higher length of disease duration compared to RR-MSnc 
(t(16) = 2.08, p = .055). A Fisher’s exact test revealed no significant differences in 
gender (p = .153), although there was a significant difference in employment status (p 
= .002). None of the above variables were considered in subsequent analysis. 
Employment status was not included in further analysis as MS patients are much less 
likely to be employed than those without MS, even at low levels of disability (Kobelt 
et al., 2017). There was a significant difference for the length of follow-up period 
between groups (F(2,34) = 18.44, p <.001). Subsequent t-tests using separate variance 
estimates revealed a significant difference between the HC group with both the RR-
MSc group (t(8) = 3.33, p = .010) and RR-MSnc group (t(8) = 3.85, p = .004). There was 
no significant difference between the MS subgroups (t(26) = 2.34, p = .08). This reveals 
that the follow-up period was significantly shorter for the HC group compared to the 
 93 
 
 
RR-MS subgroups. Nevertheless, the result implies that practice effects were 
accounted for. 
Statistical analysis was restricted to those who completed the study. Due to small 
sample size, statistical analysis examining participants who dropped out was not 
considered appropriate. However, qualitatively the reasons for drop out for the RR-
MSc group included: declined for personal reasons (1); unable to complete during 
recruitment window (1); unable to contact (1); the RR-MSnc group: declined for 
personal reasons (1); unable to complete during recruitment window (3); the HC 
group: declined for personal reasons (8); moved out of area (8); unable to contact (2). 
All participants were rated as having at least near-normal vision (logMAR ≥ 0.5) 
according to the Snellen Pocket Eye Test. It was therefore assumed that reading ability 
would not influence test performance. Therefore, no participants were excluded due 
to visual acuity concerns. 
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Table 7 Baseline demographic characteristics of all participants including those who dropped out 
Characteristic RR-MSc RR-MSnc HC Significance 
 Complete (n = 11) Dropout (n = 3) Complete (n = 17) Dropout (n = 4) Complete (n = 9) Dropout (n = 18) p value* 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD  
Age (Years) 41 8.64 42 11.53 40.94 8.86 38.75 3.95 37.78 10.29 38.44 12.89 .665 
Education 
(Years) 
13.55 1.57 15 3.61 16.06 3.21 18.75 0.96 15.67 3.91 17 2.47 .103 
PFSIQ 100.03 8.03 99.1 8.96 107.34 12.8 117.23 5.83 107.08 13.67 114.93 7.88 .251 
Disease Duration 
(Years) 
10.4 7.58 1.86 2.72 5.02 5.08 4.33 4.67 - - .055 
Follow-up period 
(Days) 
370 16.74 - 387 28.57 - 268 91.14 - <.001 
Employment: 
F/P/U 
4/1/6 1/0/2 8/7/2 4/0/0 9/0/0 17/1/0 .002A 
Gender (F/M) 6/5 2/1 15/2 0/4 7/2 10/8 .153 
SD: Standard Deviation; PFSIQ: Predicted Full-scale IQ; Employment: Full-time (F), Part-time (P), Unemployed or Sick Leave (U). *One-way ANOVA for 
participants with complete dataset only. BOLD – statistically significant. P value = .05. AFisher’s Exact test for participants with complete dataset. 
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3.5.3 Clinical Variables 
An overview of descriptive statistics for clinical variables at baseline and follow-up is 
presented in Table 8.  
Data for the ABILHAND questionnaire was only available at follow-up. A one-way 
independent ANOVA to compare ABILHAND scores revealed significant group 
differences (F(2,34) = 4.80, p = .015). As homogeneity of variance assumptions were 
not met (F(2,34) = 5.66, p = .008), post hoc Games-Howell tests showed the both the 
RR-MSc group (p = .001) and the RR-MSnc group (p = .017) scored significantly lower 
on ABILHAND compared to HC. There were no significant differences between the two 
MS subgroups (p = .617). This suggests both RR-MS groups had greater perceived 
difficulty with upper limb movement compared to HC. 
For subjective levels of fatigue, a mixed ANOVA showed a significant interaction of 
group and time (F(2,34) = 4.8, p = .015). There was a non-significant effect of time 
(F(1,34) = .016, p = .899) and a significant effect of group (F(2,34) = .016, p = .001). 
Further analysis showed that each group was significantly different from one another: 
RR-MSc vs RR-MSnc groups (p = .029), RR-MSc vs HC groups (p <.001), and RR-MSnc 
vs HC groups (p = .014). Furthermore, fatigue scores were only significantly different 
over time for the RR-MSnc group (p = .009). In combination with the mean scores, the 
results indicate that despite the magnitude of difference between groups remaining 
stable, the RR-MSnc group reported fewer symptoms of fatigue at follow-up. In 
contrast, RR-MSc and HC groups reported similar symptoms of fatigue at baseline and 
follow-up. 
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For HADS-A, there were no significant effects of time (F(1,34) = .261, p = .115), group 
(F(2,34) = .943, p = .399) or interaction (F(2,34) = .520, p = .599). In contrast, HADS-D 
had a significant main effect of group (F(2,34) = 4.07, p = .026), indicating symptoms 
of depression were different across groups. Post hoc tests demonstrated the effect 
was accounted for by a significant difference between HC and RR-MSc (p = .007). There 
were no other significant differences in terms of self-reported symptoms of 
depression between groups. No other comparisons were found to be significant (time: 
(F(1,34) = .029, p = .886; interaction: (F(2,34) = .007, p = .993). This implies that the HC 
group had significantly lower depression symptoms compared to RR-MSc. This result 
will be discussed in more detail later (Section 3.6.2). 
A mixed 2x2 ANOVA for EDSS scores revealed significant effects of group (F(2,34) = 
20.5, p <.001) and interaction (F(2,34) = 6.49, p = .017) and a non-significant effect of 
time (F(1,34) = .298, p = .590). Examination of the means suggests EDSS scores for the 
RR-MSc increased whereas RR-MSnc decreased. Post hoc t-tests compared EDSS 
scores at baseline and follow-up between both MS groups. As expected, both baseline 
(t(26) = 4.08, p > .001) and follow-up (t(26) = 4.76, p > .001) scores were significantly 
different from one another. This indicates that although there were statistically 
significant differences between the MS groups at baseline and follow-up, the rate of 
disability grew progressively worse for RR-MSc compared to RR-MSnc, which in turn, 
remained stable. There were no significant changes over time for the NARCOMS score 
(F(1,34) = 1.81, p = .19). 
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Table 8 Clinical variable scores of participants at baseline and follow-up 
Variable RR-MSc (n = 11) RR-MSnc (n = 17) HC (n = 9) p value 
 Baseline Follow-up Baseline Follow-up Baseline Follow-up 
Time x 
Group 
Time Group 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD    
ABILHAND √ - - 3.22 0.96 - - 2.61 1.35 - - 1.27 0.55 - - .015A 
FSS 5.30 1.32 5.32 1.28 4.40 1.51 3.90 1.60 2.53 0.85 2.96 1.14 .015 .899 .001B 
HADS-A 6.82 3.28 8.36 5.46 5.71 3.31 6.00 2.81 5.89 3.48 6.67 3.71 .599 .115 .399 B 
HADS-D 6.36 3.23 6.46 2.94 4.94 3.61 5.06 2.95 2.89 1.62 2.89 2.57 .993 .866 .026 B 
EDSS 4.55 0.57 4.73 0.79 3.03 1.14 2.91 1.09 - - - - .017 .590 <.001 C 
SD: standard deviation; √: Square Root; FSS: Fatigue Severity Scale; HADS: Hospital Anxiety and Depression Score, A - Anxiety score, D - Depression score; 
EDSS: Expanded Disability Status Scale; NARCOMS: North American Research Committee on MS. BOLD = statistically significant p value = .05. A One-way 
ANOVA; B 2x3 Mixed ANOVA; C 2x2 Mixed ANOVA. 
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3.5.4 Cognitive and Motor tests 
A mixed model ANOVA was used to explore the main effect of group, time and 
interaction of the factors for each of the cognitive and motor measures. The 
descriptive statistics and significance values (p = .05) for each dependent variable are 
presented in Table 9. 
(a) Cognitive Tests 
There was no significant interaction effect for the BVMT-R (F(2,34) = .387, p = .682), 
CLVT-II (F(2,34) = .991, p = .382), PASAT-3 (F(2,34) = .387, p = .682), SDMT (F(2,34) = 
.056, p = .946) or WLG (F(2,34) = .565, p = .574). The lack of significance suggests that 
the magnitude of differences across all groups remained broadly similar over the study 
period. This would imply that the cognitive profile of the RR-MSc did not significantly 
deteriorate over the course of a year in comparison to RR-MSnc and HC groups. 
There was a significant effect of time for the BVMT-R (F(1,34) = 4.74, p = .037) and the 
CVLT-II (F(1,34) = 18.83, p <.001), indicating that scores of visual and verbal memory 
improved over time. To consider this effect further, examination of means and post 
hoc tests were conducted. For the BVMT-R, there was a significant difference between 
scores at baseline and follow-up, suggesting an improvement in performance (p = .04). 
Neither the RR-MSnc or HC group had any significant differences in performance. This 
would imply that the significant effect of time for the BVMT-R was accounted for by 
an improvement in score by the RR-MSc group. In addition, further analysis of the 
CVLT-II scores revealed both the RR-MSc (p = .006) and RR-MSnc (p <.001) scored 
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significantly higher on the CVLT-II at follow-up, whereas there was no significant 
improvement for the HC group. There were no significant effects of time for IPS 
(PASAT-3: (F(1,34) = 2.32, p = .137); SDMT: (F(1,34) = 3.69, p = .063)) or verbal fluency 
(WLG: (F(1,34) = .913, p = .346)). 
Finally, there was a significant effect of group for the CVLT-II (F(2,34) = 8.52, p = .001), 
PASAT-3 (F(2,34) = 4.48, p = .019), SDMT (F(2,34) = 6.12, p = .005) and WLG (F(2,34) = 
4.94, p = .013). Interestingly, there was no significant group effect for the BVMT-R 
(F(2,34) = 2.18, p = .129). For the CVLT-II, post hoc comparisons revealed there was a 
significant difference between the RR-MSc and RR-MSnc group (p = .002) and the HC 
group (p = .005) but no significant difference between the RR-MSnc and HC groups (p 
= .999). This pattern was also repeated for the PASAT-3 (RR-MSc vs RR-MSnc, p = .008; 
RR-MSc vs HC, p = .024; RR-MSnc vs HC, p = .963), SDMT (RR-MSc vs RR-MSnc, p = 
.007; RR-MSc vs HC, p = .003; RR-MSnc vs HC, p = .457) and the WLG (RR-MSc vs RR-
MSnc, p = .013; RR-MSc vs HC, p = .007; RR-MSnc vs HC, p = .052). Taken together, the 
results suggest that the group effect was largely accounted for by the superior 
performance on a range of cognitive abilities by the RR-MSnc and HC groups compared 
to RR-MSc. There were no significant differences between RR-MSnc and HC groups. 
(b) Motor Tests 
A similar strategy was utilised to examine the performance of motor tasks. There was 
no significant interaction effect for the NPHT (F(2,34) = .047, p = .954), GPT (F(2,34) = 
.885, p = .422) or MPI (F(2,34) = .138, p = .872. There was also no significant effect of 
time for the NHPT (F(1,34) = .373, p = .545), GPT (F(1,34) = .904, p = .348) or MPI 
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(F(1,34) = 1.51, p = .226). The results indicate motor function and motor planning 
remained stable across all groups and again implies the RR-MSc group did not 
significantly deteriorate compared the other groups as was previously predicted. 
As expected, there was a significant effect of group for NHPT (F(2,34) = 29.11, p <.001), 
GPT (F(2,34) = 11.74, p <.001) and MPI (F(2,34) = 14.19, p <.001). Inspection of the 
means and post hoc analysis revealed that for the NHPT there was a significant 
difference between the RR-MSc and RR-MSnc groups (p = .001) and HC groups (p 
<.001). Furthermore, there was a significant difference between the RR-MSnc and the 
HC group (p = .004). This pattern was also demonstrated for the GPT (RR-MSc vs RR-
MSnc, p = .041; RR-MSc vs HC, p = .006; RR-MSnc vs HC, p = .003) and the MPI (RR-
MSc vs RR-MSnc, p = .023; RR-MSc vs HC, p = .001; RR-MSnc vs HC, p = .003). The 
results show that there was significant magnitude of difference between each group: 
the HC group outperformed the RR-MSnc group, who in turn, outperformed the RR-
MSc group on measures of motor functioning and motor planning.   
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Table 9 Baseline and Follow-up scores for cognitive and motor tasks and results of mixed ANOVA significance levels 
 RR-MSc (n= 11) RR-MSnc (n= 17) HC (n= 9) Significance (p-value) 
Test Baseline Follow-up Baseline Follow-up Baseline Follow-up TxG Time Group 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD    
BVMT-R 19.00 9.77 20.82 10.22 24.65 8.15 26.82 6.37 24.89 5.53 25.56 5.25 .682 .037 .129A 
CVLT-II 38.82 9.01 45.73 11.09 52.18 11.27 59.53 9.76 55.22 8.23 58.22 10.34 .382 .001 <.001 
PASAT-3 34.09 12.77 36.00 12.97 45.29 9.41 46.65 10.64 45.22 7.45 46.33 7.65 .946 .137 .019 
SDMT 39.73 10.57 42.09 9.88 52.06 11.86 54.88 14.78 56.67 8.92 57.22 8.91 .639 .063 .005 
WLG 23.18 5.38 22.18 7.43 28.24 4.8 28.53 7.44 30.56 3.57 29.22 5.61 .574 .346 .013 
NHPT 28.61 5.51 28.56 7.59 21.22 2.26 20.83 3.12 18.32 1.29 18.15 1.43 - - - 
NHPT 
Log10 
1.45 0.08 1.44 0.1 1.33 0.05 1.31 0.06 1.26 0.03 1.26 0.04 .954 .545 <.001A 
GPT 96.97 37.12 102.4 43.53 65.62 16.33 65.02 11.81 51.78 2.54 52.69 2.62 .422 .348 <.001A 
MPI 68.35 33.42 73.93 36.95 43.81 13.87 44.19 9.67 33.35 2.21 34.49 2.14 - - - 
MPI 
Log10 
1.8 0.18 1.82 0.2 1.62 0.12 1.64 0.1 1.52 0.03 1.54 0.03 .872 .226 <.001A 
SD - standard deviation; BOLD – significant result using P value = .05. All analysis conducted with a 2x3 ANOVA with Least Significant Difference or A 
Games-Howell. 
 102 
 
 
3.5.5 Correlations of Motor Function, Planning and Information Processing Speed 
Correlations between measures of IPS and motor tasks from data collected at 1-year 
follow-up are presented in Table 10. The results indicate that the SDMT was more 
strongly correlated with the motor tests compared to the PASAT-3. This implies that 
there was a moderate negative correlation for the SDMT and all motor tests, indicating 
that there was a tendency for low SDMT scores to go with slower performance on 
both tasks of motor functioning (NHPT) and motor planning (MPI), thus highlighting 
inefficiencies.  
Table 10 Correlations of IPS and self-reported motor difficulties with motor function and 
planning 
 SDMT PASAT-3 ABILHAND 
 r p r p r p 
NHPT -.67 <.001 -.52 .001 .39 .017 
GPT -.61 <.001 -.52 .001 .35 .033 
MPI -.61 <.001 -.5 .002 .37 .026 
BOLD: Significant at the 0.05 level. r = Pearson’s 
Fisher transformations were computed to ascertain whether there was a statistically 
significant difference between correlation coefficients. The SDMT revealed no 
significant difference between correlations coefficients for NHPT v GPT (z = -.44, p = 
.66), GPT v MPI (z = 0, p = 1) or NHPT v MPI (z = -.44, p = .66). For the PASAT-3, there 
was no significant difference between correlation coefficients for NHPT v GPT (z = 0, p 
= 1), GPT v MPI (z = -.12, p = .91), or NHPT v MPI (z = -.12, p = .91). This suggests that 
IPS is not contributing more to motor planning than motor function. 
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An exploratory approach evaluating the relationship between subjective motor 
performance (ABILHAND) and objective motor functioning (NHPT and GPT) was also 
undertaken and results are presented in Table 10. The results indicate that there was 
a weak positive correlation between subjective and objective motor performance 
suggesting a linear relationship between perceived difficulties and slower motor 
performance. ABILHAND was not significantly correlated with any other self-report 
measure (e.g. FSS, HADS). 
3.5.6 Summary 
The results indicate all groups were successfully matched on all demographic variables 
aside from employment status. As expected, there were significant differences 
between RR-MS subgroups on the EDSS and NARCOMS score. There was a significant 
difference in symptoms of depression between groups, with HC reporting significantly 
lower symptoms of depression compared to RR-MSc. There were no differences in 
symptoms of anxiety. The cognitive profile of each group remained broadly similar 
between baseline and follow-up. HC did not outperform the RR-MSnc on any measure. 
However, HC did significantly outperform RR-MSc on the SDMT and CLVT-II. RR-MSnc 
significantly outperformed RR-MSc on the SDMT, PASAT-3 and CLVT-II. On tests of 
motor function and motor planning, HC significantly outperformed RR-MSnc (aside 
from the NHPT) and RR-MSc, and RR-MSnc outperformed RR-MSc. There was a 
significant negative moderate-strong correlation between the MPI and measures of 
IPS. However, there were no significant differences between the strengths of the 
correlations for the MPI, GPT and 9HPT with either measure of IPS. 
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3.6 Discussion 
3.6.1 Summary 
There is a consistent pattern demonstrating cerebellar signs and cognitive dysfunction 
often occur in parallel and RR-MSc is associated with more widespread and severe 
cognitive impairment. To develop a clearer measure of cerebellar involvement, the 
present study investigated the longitudinal relation of cognition to cerebellar function 
in RR-MS and how changes relate to motor planning and function.  
3.6.2 Hypothesis (i): The baseline finding that patients with RR-MSc have a 
differential cognitive profile to RR-MSnc and HC, demonstrated by worse 
performances on tests of IPS, memory and verbal fluency will be replicated 
at 1-year follow-up.  
The RR-MSc group were significantly outperformed by RR-MSnc and HC groups on all 
cognitive measures aside from the BVMT-R. There were no significant differences 
between RR-MSnc and HC groups. The results suggest that the cognitive profile of RR-
MSc appears to be consistently weaker when compared to RR-MSnc and HC, involving 
more severe and widespread cognitive impairment. This replicates the baseline 
finding that a differential cognitive profile exists for RR-MSc compared to RR-MSnc 
and HC (Hinchcliffe, 2017). These findings are possibly associated with the ‘universal 
cerebellar transform’, suggesting that cerebellar damage would result in impairment 
across several domains (Koziol et al., 2014; Schmahmann, 2004).  
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As all groups were successfully matched for age, gender and premorbid IQ, these 
variables cannot account for the differences observed. There were however 
statistically significant differences between the MS and HC groups in self-reported 
depression and fatigue. As the prevalence of depression and fatigue is higher in MS 
populations than the general population (Boeschoten et al., 2017; Weiland et al., 
2015), the finding might represent an inherent difference between groups rather than 
noise or error variance. Attempting to control pre-existing, meaningful group 
differences is not recommended as it may lead to the removal of telling variation 
(Miller and Chapman, 2001). Therefore, a decision was taken not to statistically 
control for these variables.  
The follow-up period was also significantly shorter for the HC. Due to a large amount 
of attrition, more controls were recruited to negate the loss. Consequently, the time 
between baseline and follow-up was inevitably shorter. A study of practice effects 
using a similar neuropsychological battery in healthy adults found test intervals of 6 
months or more were largely resistant to practice effects (Bartels, Wegrzyn, Wiedl, 
Ackermann, & Ehrenreich, 2010). Moreover, the inclusion of controls with a shorter 
follow-up would have clearly accounted for any practice effects in the MS groups. 
Therefore, as the mean follow-up period for HC was more than six months, no efforts 
were made to control for the difference. 
The RR-MSnc and HC group performed significantly better on both measures of IPS 
compared to the RR-MSc. This replicates findings from baseline data and previous 
studies (Cerasa et al., 2012; Damasceno, Damasceno & Cendes, 2014; Moroso et al., 
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2017; Ruet et al., 2014; Valentino et al., 2009; van de Pavert et al., 2016; Weier et al., 
2014) and provides theoretical support that cerebellar integrity is crucial for cognitive 
efficiency as measured by IPS. The SDMT is a superior measure of IPS (Benedict et al., 
2017), and therefore it is of relevance that the SDMT had larger significant group 
differences compared to the PASAT-3, which contains addition components (i.e. 
arithmetic and working memory; Costa, Genova, DeLuca, & Chiaravalloti, 2016). This 
provides strong evidence of IPS vulnerability in relation to cerebellar damage.  
There were significant verbal memory deficits for the RR-MSc group, as indicated by 
CVLT-II performance, that were replicated over the testing period. In contrast, no such 
replication was found for visual memory, represented by BVMT-R performance. The 
absence of a significant group difference for BVMT-R could be related to the high 
standard deviation indicating scores were widely spread and thus making it more 
difficult to detect an effect. From clinical observations, it is important to state that the 
drawing component of the BVMT-R was unaffected by cerebellar signs.  
However, examination of CVLT-II and BVMT-R means reveals a consistent pattern 
whereby RR-MSc performed worse than the other groups. This pattern of results 
might reflect that both measures were revised from the original format (e.g. delayed 
recall performance was removed), which may have affected the psychometric 
properties. In addition, although both verbal and visual memory deficits have been 
found to be associated with cerebellar signs (van der Pavert et al., 2016), this finding 
has not always been replicated (Ceresa et al., 2013; Valentino et al., 2009). Another 
reason for the discrepancies might be related to the study being underpowered which 
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will be discussed in later sections. Nevertheless, despite evidence of variability, the 
findings to some extent demonstrate memory deficits for the RR-MSc group were 
replicated at baseline and follow-up.  
Finally, there were consistent deficits in verbal fluency as measured by WLG. This 
replicates previous findings for verbal fluency tests in MS (e.g. Bodini et al., 2013; 
Hynčicová et al., 2017; Morrow, Menon, Rosehart, & Sharma, 2017) as well as 
significant differences found between RR-MSc and RR-MSnc (Ceresa et al., 2012; 
Valentino et al., 2009). It is possible that a lack of efficient integration between the 
frontal lobes and the cerebellum are responsible for executive dysfunction and 
therefore optimal performance is reliant on intact cerebellar function. This finding 
might be related to ‘cognitive compensation failure’ whereby the forced recruitment 
of alternative regions to aid task performance led to a decrease in efficiency as 
indicated by the reduction in words generated by the RR-MSc group. 
3.6.3 Hypothesis (ii): The performance of patients with RR-MSc on cognitive and 
motor planning tasks will decline over a 1-year period compared to patients 
with RR-MSnc and HC, who in turn, will remain stable. 
In contrast to the prediction that the RR-MSc group would decline on cognitive and 
motor planning tasks compared to other groups, the results indicated that the 
magnitude of differences remained stable. Previous research demonstrated sensitivity 
of the SDMT and PASAT to cognitive decline in individuals with RR-MS within a similar 
time frame (López-Góngora, Querol, & Escartín, 2015). One explanation for the 
discrepancy might be related to the small sample size of the RR-MSc group and again 
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whether there was sufficient power to detect changes. For instance, the 
aforementioned study had longitudinal data for 196 MS patients. Furthermore, the 
follow-up was relatively short compared to other studies investigating cognitive 
decline. To illustrate, two studies investigating disease-related cognitive decline used 
a follow-up period of 10 years (Amato et al., 2001; Schwid et al., 2007). It is likely that 
having longer periods of observation with increased sample size might have yielded a 
more robust sensitivity to change. 
Upper limb function is of particular importance in MS (Burke, 2018; Lamers & Feys, 
2014). Yet further research is needed to establish the validation of cut-off scores for 
normal versus abnormal function and meaningful change in test scores (Feys et al., 
2017). Longitudinal data of over 2 years have suggested a change of 15%–20% of the 
NHPT baseline value appears robust in differentiating between progression or stability 
in MS patients (Kragt, van der Linden, Nielsen, Uitdehaag, & Polman, 2006; van 
Winsen, Kragt, Hoogervorst, Polman, & Uitdehaag, 2010). Thus, using a more stringent 
cut-off of a 15% change as a sign of progression, the data revealed relative stability for 
the NHPT as only 2/11 RR-MSc showed signs of progression compared to 1/17 of RR-
MSnc and 0/9 HC.  
Interestingly, application of similar principles to the MPI reveals the RR-MSc group 
were not as stable as initially thought. Again, using a 15% cut-off it appears that 7/11 
RR-MSc compared to 2/17 RR-MS and 1/9 HC group showed a deterioration in MPI 
performance. This potentially provides support for the MPI as a useful tool in aiding 
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early identification of MS patients at risk of decline. However, without further 
psychometric and MRI validation, any interpretation remains highly inferential. 
It is worth considering that although both RR-MSnc and HC outperformed the RR-MSc 
group, RR-MSnc and HC did not differ significantly aside from on the GPT and MPI. 
Previous research has suggested that significant differences might also have been 
expected (Langdon, 2011). Given the cognitive deficits of the RR-MSc group, perhaps 
the pooling of RR-MSc and RR-MSnc groups in the generation of normative data is one 
factor to explain this discrepancy, and thus stresses the importance of trying to reduce 
variation in a heterogenous condition. On the other hand, it might also suggest that 
the GPT and MPI are more sensitive to detecting subtle differences which are not 
captured with cognitive measures in short follow-up periods. Theoretically, the GPT 
and MPI involve more motor planning components and therefore are particularly 
susceptible to cerebellar damage. Thus, the highly significant differences between RR-
MSnc and HC on motor planning ability might represent the presence of increased 
cerebellar involvement. 
Related to the above point, there was evidence of progression in the EDSS score for 
the RR-MSc group that was not replicated in any cognitive measure. This might be 
explained by weight attributed to certain functions (e.g. limb function) or questionable 
psychometric properties of the EDSS (Hobart, Freeman, & Thompson, 2000), but it 
also highlights the complex relation between cognition, motor function and disability 
and the need to develop better tools to understand this interaction. 
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3.6.4 Hypothesis (iii): Differences in motor planning will be related to differences 
in information processing speed at 1-year follow-up. 
The MPI served as a measure of motor planning, which in turn, was used as a putative 
surrogate of cerebellar integrity. Data collected at 1-year follow-up demonstrated a 
moderate strength in the relationship between reduced IPS (SDMT/PASAT-3) and 
slower performance on tests of motor function (NHPT) and motor planning (GPT/MPI). 
As predicted, the purer measure of IPS, the SDMT, was more strongly correlated with 
the MPI than the PASAT-3. As there were no significant differences in the strengths of 
the correlations between motor function and motor planning, it can be deduced there 
is no unique contribution of IPS to motor planning.  
Nevertheless, the correlations indicate support for previous findings by Bonnet et al. 
(2010) and Ruet et al. (2014) suggesting ‘cognitive compensatory’ strategies. The 
results also replicate findings from baseline data (Hinchcliffe, 2017). One explanation 
might be that MS-induced damage to cortico-cerebellar loops triggers functional 
changes and possibly compensatory recruitment of cortical regions usually preserved 
for higher-order tasks. As a by-product, this may lead to a saturation effect on 
cognitive load and a reduction in cognitive efficiency which is reflected in IPS 
measures. Several task-related fMRI studies have demonstrated evidence of altered 
connectively in the cerebellum (Rocca et al., 2017; Rocca et al., 2012; Saini et al., 
2004). This theory might explain the highly significant differences between all group 
levels for motor planning tasks: HC significantly outperformed RR-MSc, who 
significantly outperformed RR-MSnc. It appears compensatory strategies mediated 
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the loss of cognitive ability through task completion, yet the increasing burden led to 
an overreliance on cortical regions for higher order thinking and thus progressively 
worse MPI scores. 
The inclusion of the ABILHAND questionnaire was to enable comparisons between a 
novel synthesis of objective and subjective motor function and motor planning. As 
there were only weak correlations, findings suggest that the measure might be not 
adequately capturing upper limb functional difficulties in MS. This is also supported 
by the non-significant difference in mean scores between RR-MSc and RR-MSnc, who 
undoubtedly have differences in motor function. This reflects a wider issue, whereby 
there is a lack of subjective outcome measures to capture upper limb dysfunction and 
more research is clearly required. Moreover, the finding exemplifies the difficulties 
with self-report questionnaires which are known to be affected by psychosocial 
factors (Nauta et al., 2018). 
3.6.5 Limitations 
Despite employing strict inclusion criteria, there was evidence of heterogeneity in the 
RR-MS groups. This makes it more challenging to assess the contribution of the 
cerebellum to cognition as patient variability may mask true effects. For example, 
results showed that RR-MSc group had significantly higher EDSS scores and a longer 
disease duration than the RR-MSnc group. This is potentially problematic as one study 
of MS patients with a minimum disease duration of ten years found there was no 
relationship between cerebellar function and cognitive impairment (Daams et al., 
2017). As the present study did not include imaging methods to corroborate lesions in 
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the cerebellum, perhaps findings are more closely associated with global pathology 
rather than cerebellar pathology. Alternatively, findings could merely represent 
different stages in the progression of MS. On the other hand, the influence of disease 
variables is not always consistent in research (Langdon, 2011). 
Concerns with the neuropsychological battery were also noted which may have 
precluded further conclusions. There was only a single measure of executive function, 
a domain associated with frontal regions and encompassing several higher-order 
cognitive abilities. Inclusion of another test such as the Delis-Kaplan Executive 
Function System (D-KEFS) colour-word interference (Delis, Kaplan, & Kramer, 2001) 
might have allowed for further exploration of the central hypothesis that the 
cerebellum disencumbers the cognitive load of frontal regions. Furthermore, IPS has 
been considered as the unitary underlying deficit in MS (Denney, Lynch, Parmenter, & 
Horne, 2004). Therefore, the battery may have benefited from the inclusion of tests 
without a timed component to negate any unwanted influence of IPS. For example, 
inclusion of the Figure Copy and Short Story subtest from the Adult Memory and 
Information Processing Battery (Coughlan & Hollows, 1985) for visual and verbal 
memory. Similarly, to extricate IPS from attentional processes, specific attention tasks 
might have been beneficial. Despite these limitations, the selected battery utilised 
internationally recognised tests of MS, including the BICAMS, and has been found to 
demonstrate sensitivity and specificity to cognitive impairment in MS. As such, the 
battery was considered suitable to effectively test the proposed hypotheses. 
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To infer motor planning ability using subtraction logic, there must be an assumption 
of shared homogeneity in task components. However, there are several variations 
between the NHPT and GPT which were not taken into consideration when used to 
compute the MPI. Although both peg board tests require coordination of perceptive, 
visuospatial and motor functions, the GPT has a larger field of operations than the 
NHPT (20 pegs to position as opposed to 9 pegs); requiring additional dexterity and 
precise motor control. Furthermore, there are differences in task complexity. 
Participants are provided with additional instructions for the GPT (i.e. placing pegs 
sequentially), whereas the NHPT relies on intuition to complete the task. These 
additional executive demands may also have influenced performance. Therefore, a 
key limitation of the MPI is the unequal sensorimotor components of the NHPT and 
GPT, thereby reducing confidence in any presumed assumptions. 
It is also important to acknowledge the circularity of using motor function tasks in a 
group defined by difficulties with tremor and coordination. This questions whether 
results merely reflect pre-existing sensorimotor effects rather than differences in 
motor planning ability. To address the issue of circularity, it would be useful to corroborate 
findings through the employment of neuroimaging techniques to confirm the presence of 
lesions in the cerebellum. 
There were also methodological concerns within the study that might have hampered 
the strength of conclusions drawn. Firstly, the high rate of attrition (20% for MS groups 
and 70% for HC) raises the possibility of bias and questions the validity of the results. 
Attempts to alleviate concerns about potential differences between those completed 
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and dropped-out were made by providing a baseline table with demographic 
information. Given the small sample, further statistical analysis was not warranted, 
and visual inspection of data deems it was unlikely results would have been 
significantly influenced. However, a possibility of bias remains. 
Related to attrition was the issue of small sample size and thus the study being 
underpowered to detect effects. The observed effect sizes for the SDMT were as 
follows: main effect of group, d = 1.2; main effect of time d = 0.7; and, main effect of 
interaction d = 0.3. This implies that the study was sufficiently powered for detecting 
main effects of group and time, but underpowered for detecting any interactions and 
therefore at risk of type II error. Increasing sample sizes may have yielded improved 
confidence in results drawn, although this was hard to achieve in the context of a 
longitudinal design. 
Multiple tests on the same experimental data increases the familywise error rate and 
likelihood of type I error. Post-hoc adjustments of the p-value are often implemented 
to reduce the chance of making type I error. However, if a test is too conservative then 
it is likely to result in a lack of statistical power and increase likelihood of type II error 
(Field, 2009). Within the study, multiple statistical analyses were carried out due to 
the number of tests included in the battery. Attempts to correct the p-value would 
result in a very stringent p-value and the risk of rejecting meaningful group 
differences. Therefore, following recommendations by Perneger (1998), a decision 
was made not to make corrections to the p-value. Accordingly, results should be 
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interpreted with caution due to lack of control over the familywise error rate and 
increased propensity of type I error. 
3.6.6 Implications 
Despite the wide prevalence, the pattern of cognitive impairment is not uniform; 
moreover, there is evidence of distinct patterns of cognitive impairment (i.e. cognitive 
phenotypes) (Leavitt, Tosto, & Riley, 2018). The study provides evidence that 
cerebellar symptomatology may be associated with a distinct cognitive phenotype 
characterised by more severe and widespread damage. The use of phenotypes in 
future research may help reduce patient variability and more personalised medicine. 
This aligns with research in other neurological conditions such as dementia, whereby 
more tailored interventions have used cognitive phenotypes considered at greater risk 
of progression (Belleville, Gauthier, Lepage, Kergoat, & Gilbert, 2014). Thus, the 
findings highlight the benefit of adopting phenotypes to address issues with patient 
heterogeneity. As a result, future research studies would also be better equipped to 
evaluate the discrete features of the disease. 
Considering RR-MSc is indicative of poor prognosis (Amato et al., 2010), the group 
serve as a viable target for differential treatment approaches. For example, there is 
growing interest in the use of cognitive rehabilitation interventions as a result of 
evidence associating cognitive training (CT) and cognitive benefit in populations with 
mild cognitive impairment (Campbell, Langdon, Cercignani, & Rashid, 2016; Reijnders, 
van Heugten, & van Boxtel, 2013; Sumowski et al., 2018). Preliminary evidence for CT 
in MS have demonstrated benefits in several domains including IPS, memory and 
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executive functions (Amato et al., 2014; De Giglio et al., 2015; Messinis et al., 2017; 
Pérez-Martín, González-Platas, Eguía-Del Río, Croissier-Elías, & Jiménez Sosa, 2017). 
Therefore, the findings of the study could support the proposal of new clinical 
treatment pathways tailored for RR-MSc, with more emphasis on neuropsychological 
assessment and cognitive rehabilitation. This might provide benefits for those with 
RR-MSc through early identification and intervention as well as cost-efficiencies for 
services through appropriate allocation of resources.  
There are several theoretical ramifications of the study. Chiefly, the study provides 
support that cerebellar integrity is vital for optimal cognitive and motor performance 
and damage is associated with reduced inefficiencies through the loss of automated 
subroutines and forced recruitment of cortical regions. This is the first study to 
demonstrate the link using motor planning, a higher-order cognitive ability, within a 
longitudinal design. The MPI appears to be a useful tool with seemingly good test-
retest reliability, although it would benefit from further research to establish 
psychometric properties. In addition, combining data with neuroimaging techniques 
to corroborate cerebellum pathology and the use of functional MRI to provide 
evidence of compensatory cortical recruitment would also increase the theoretical 
confidence in the conclusions drawn. 
3.6.7 Future research  
A further study with increased sample sizes, longer periods of observation and 
continuing to use an active control group to control for non-specific effects is required. 
Rigorous participant selection using neuroimaging techniques for more accurate 
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diagnosis of those with cerebellar symptomatology should also be used. The inclusion 
of a more expansive executive function battery might also aid understanding of 
important theoretical underpinnings and further substantiate the cognitive profile of 
RR-MSc.  
The MPI is a promising new measure for the field. The next step would be to conduct 
a MRI study to validate that the MPI is linked to cerebellar lesion load and atrophy. 
From a theoretical perspective, this would substantiate that motor planning is a key 
factor in the disability that cerebellar involvement imposes and ensure that results do 
not merely reflect the influence of disease severity. 
Furthermore, to enable clearer interpretation of the MPI, it would be useful to address 
some of the methodological concerns by the manufacture of a new pegboard with 
equal sensorimotor components to the GPT but without the motor planning 
component. Cardboard versions with equitable psychometric properties to the plastic 
versions are entering research which would suggest this is a feasible and cost-effective 
option (Dubuisson et al., 2017). The development and refinement of an MPI measure 
also aligns with research priorities around upper limb dysfunction (NICE, 2014) and 
therefore potentially provides an informative tool for future clinical and research 
purposes. The clinical usefulness of the MPI would also benefit from the generation of 
age-matched norms and development of meaningful change scores. 
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3.7 Conclusion 
The present longitudinal study aimed to explore the relation of cognition to cerebellar 
function using a novel motor planning measure. Results consistently demonstrated a 
differential cognitive profile for RR-MSc characterised by greater impairment in tests 
of cognition, motor function and motor planning. The poor performance of the RR-
MSc group on the GPT and MPI implies the likelihood of a cerebellar effect on motor 
planning, which could not be explained by increased sensorimotor deficits. 
Theoretically, the reduced performance is thought to related to a reduction in 
cerebellar function through the loss of subroutines which are considered important 
for driving wider network efficiency. Evidence supporting this theory was shown by 
moderate to large negative correlations between the MPI, a putative surrogate of 
cerebellar integrity, and measures of IPS, the domain most susceptible to MS 
pathology. 
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4. Integration, Impact and Dissemination Summary 
 
 
 120 
 
 
4.1 Integration 
The aim of the thesis was to investigate the longitudinal relation of cognition to 
cerebellar function in Relapsing-Remitting Multiple Sclerosis (RR-MS), and how 
changes relate to motor planning and function. The intention was to use the 
systematic review as an opening to the topic of cognitive impairment in MS and the 
relationship to cerebellar function. This provided a comprehensive background so that 
the empirical study could address specific questions about how motor planning relates 
to cognition over a year. The integration process provided several challenges such as 
how to focus on a specific area of cognition, extending the work from an earlier 
DClinPsy project and encountering issues with attrition. Therefore, this section covers 
how issues were address and to what extent the aim was accomplished. 
Given the vast literature on cognition in MS, it was important that a more precise 
aspect of topic was established. Discussions with my supervisor revealed it was 
becoming increasingly recognised that individuals with MS who show physical 
symptoms of cerebellar involvement such as tremor and poor coordination, have a 
differential cognitive profile. Therefore, it was agreed that the thesis should focus on 
the cognitive difficulties experienced by individuals with MS and cerebellar symptoms. 
This would enable a novel exploration of recent phenomena and align with research 
objectives recommended by a NHS report expressing a need to develop a better 
understanding of cognition in MS. 
Consequently, the systematic review provided an opportunity to summarise the 
impact of the cerebellum to cognition and related-variables in MS. This was useful in 
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aiding my own understanding of the field but also to provide the reader with a 
comprehensive background of the aetiology and symptomatology of MS. This was a 
significant component to the integration as it meant the empirical study could 
subsequently use the review as a foundation for more detailed explanation of 
complicated topics. Furthermore, the review provided clarity as to what areas 
required more research and, more specifically, what was the general problem that 
needed to be addressed by the empirical study. As such, the identification of a specific 
topic and the refinement of a problem through an objective review of the literature, 
certainly aided the integration of the thesis. 
Researching the systematic review also coincided with a placement at a 
neuropsychological department. The placement predominately involved conducting 
comprehensive neuropsychological assessments for a range of conditions including 
MS. Working in a department related to the thesis topic was beneficial for several 
reasons. For the systematic review, increasing my knowledge of brain function and 
understanding of psychometrics meant I was better equipped to comprehend 
terminology in papers and to critique research methodology and findings. In addition, 
with the experience of conducting multiple assessments I became more confident 
with the administration and interpretation of the various neuropsychological tools. 
This was helpful during data collection for the empirical study whereby my experience 
meant I was more efficient in the delivery of the test battery. Moreover, the 
placement offered an opportunity to learn more about the differential 
neurorehabilitation treatments for MS, which had direct links with recommendations 
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outlined by the thesis. The concurrent clinical experience complemented the research 
and had a positive influence on the integration of thesis components. 
The thesis was a longitudinal study based on previous baseline work completed by 
another trainee. There were several challenges linked to the integration of the two 
studies. For example, the original study was initially conceived using a cross-sectional 
design. As such, adding a longitudinal component meant further considerations 
required attention if the follow-up study was to be a success. To overcome issues 
required periodic communication between the researchers and the clinical team to 
ensure everyone was aware of the shared vision for the research. Practical steps were 
also taken such as obtaining permission from relevant ethical boards for myself to aid 
with recruitment to counter potential issues of attrition. This additional input to the 
formative stages of present thesis was essential in safeguarding the success of the 
empirical study when later difficulties occurred. 
In contrast, building on a previous study also provided benefits which strengthened 
the integration. For example, a concern raised with the initial findings was that visual 
acuity may have accounted for performance in certain neuropsychological tests. 
Liaising with the research team meant that the study protocol could be amended to 
include a test of vision to account for the potential influence. From a theoretical 
perspective, adding a longitudinal component to a pre-existing study also meant that 
additional aspects of research could be explored such as the dynamic of time. This was 
relevant as the systematic review identified the lack of follow-up data as a criticism of 
the field. 
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An initial draft of the empirical paper was presented to service users affected by MS 
and they were invited to share comments on the acceptability of the study 
methodology. Although no subsequent changes were made, opening conversations 
was useful in reflecting how to use real-life examples to explain the nature of the 
investigation and ‘humanising’ the research (Youngson & Blennerhassett, 2016). 
Furthermore, this experience had repercussions in terms of how to maximise the 
impact of research findings and an example of how various factors have influenced 
the thesis.  
One of the difficulties encountered was the amount of attrition. Although attempts 
were made to minimise the impact of attrition (e.g. additional participant 
recruitment), it was hard to predict how many participants would be lost to follow-up. 
In total, retention was approximately 80% for the MS groups, whereas it was much 
lower for controls at around 20%. The first indication that attrition might be a concern 
was when 16 controls dropped out over the course of two days. The loss had several 
implications. Since the sample size estimates were the minimal to allow sufficient 
power to detect large effect size differences, one implication was that falling short of 
required sample size might preclude certain statistical analysis. Certain measures 
were taken to try to address these issues. For instance, a decision was taken to pool 
data from all groups to estimate the correlation between measures of interest rather 
than analyse separate groups. However, a wider implication for the study was whether 
there was sufficient power to test hypotheses. If the study was underpowered to 
detect effects, then conclusions must be taken with caution. 
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Overall, I am pleased with the integration of the multiple components of the thesis. I 
wanted the thesis to have a clear narrative, beginning with the wider issues faced by 
those living with MS before focusing on a pertinent issue and conducting clinically-
relevant research to address the problem. The context of the thesis was influenced by 
personal experiences, supervision, clinical experience on placement and valued input 
from other members of the research team.  
  
  
 125 
 
 
4.2 Impact 
The wide heterogeneity observed in the MS population is one factor that has 
hampered efforts to develop effective treatments. Therefore, a clearer understanding 
of the heterogeneity is needed to advance understanding and enable tailored 
therapeutic strategies. The thesis findings suggest that patients with RR-MS can be 
categorised further as having cerebellar signs (RR-MSc) or no cerebellar signs (RR-
MSnc). In RR-MSc, the cognitive profile is characterised by greater impairment and 
associated with a worse prognosis compared to RR-MSnc. Although the development 
of specific MRI and neuropsychological criteria would further validate the RR-MS 
subtypes, these preliminary findings are significant as they represent a feasible means 
to reduce patient heterogeneity. 
There are several benefits associated with the use of distinct subtypes. From a 
research perspective, targeted enrolment of RR-MSc has the potential aid study 
designs. For example, it might provide greater clarity in MRI studies investigating 
structural and functional changes in cortico-cerebellar loops by the reduction of 
variation. This would help understand consequences of MS damage and hence inform 
theoretical models such as the role of subroutines. Furthermore, it might provide a 
reasonable answer to discrepancies found in pre-existing research investigating 
cognition in MS whereby RR-MS subtypes are pooled together (e.g. Damasceno, 
Damasceno, Cendes, Tinelli, & Benner, 2014; Romascano et al., 2015). 
For clinicians, the findings provide prognostic information about cognition and motor 
planning for patients with RR-MSc. This could be useful in providing members of the 
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clinical team a greater insight into the likelihood of expected difficulties (e.g. mental 
health, employment) and facilitate more personalised information sharing and 
education for the person and the family. Enabling honest and open conversations is 
also a precursor for effective preparation for the future. For example, proactive 
referrals to vocational support services to ensure reasonable adjustments are in place 
to aid job retention. This appears to be particularly important given the significantly 
lower rates of employment found in the study for the RR-MSc group. 
As the RR-MSc group were considered at risk of greater cognitive impairment then 
identification might lead to an earlier intervention of cognitive rehabilitation. One 
area that continues to grow in popularity is computerised cognitive training (CCT). CCT 
refers to interventions that aim to improve cognitive domains through repeated 
practice on theoretically motivated skills and strategies. It has been proposed that 
participation in mentally stimulating activities offers protection from neuropathology 
via a cognitive reserve. The theory states that persons with a higher reserve can 
withstand more severe neuropathology before suffering cognitive impairment (Stern, 
2006). Consequently, CCT provides an opportunity to continue engaging in mentally 
stimulating activities, which in turn may offer further protection.  CCT can be used 
without significant cognitive or functional difficulties and is therefore well suited for 
individuals with RR-MSc. The therapeutic potential of CCT of RR-MSc is unknown, yet 
CCT represents an example of new opportunities for targeted interventions which may 
be beneficial for a group with traditionally poor rehabilitation outcomes. 
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Upper limb functional impairment remains a key priority for future research. The 
#ThinkHand campaign was launched in 2016 to raise awareness of hand and arm 
function within the MS community. The movement has found many people with MS 
rate upper limb function as more important than lower limb function for 
independence and quality of life. Objectives of the campaign include advocating for 
the use of the Nine-hole Peg Test (NHPT) as a primary outcome measure and the 
development of a new outcome measures for assessing hand function. The thesis has 
several implications for the campaign and may offer a beneficial impact through 
alignment with certain objectives. For example, the study used the NHPT as a primary 
outcome measure, considered the properties of a new self-report upper limb measure 
(i.e. ABILHAND) and proposed the use of a novel outcome measure based on motor 
planning function. It is hoped that the findings will help the campaign to gain further 
momentum and influence regulatory authorities to shift focus onto upper limb 
function.  
The Motor Planning Index (MPI) represents a potential new outcome measure for 
clinicians in the field of MS. To maximise the benefit of the tool, correlations with MRI 
data and psychometrics would need to be researched and published. If realised, the 
tool could be publicised as a quick and easy to administer test to obtain rapid 
information about the integrity of the cerebellum. This would be beneficial for 
clinicians in providing a measure of sensorimotor function, upper limb dysfunction and 
motor planning ability. This information would provide an estimate of potential life 
restrictions and disability and furthermore aid consultations with patients and family. 
Furthermore, it could be incorporated as a key outcome measure for the use of 
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pharmacological interventions given the breath of information it provides or as part 
of safety planning (e.g. assessment of driving proficiency).  
One of the research objectives was the synthesis of objective and subjective motor 
function. This was part of a wider effort to enhance understanding of upper extremity 
function in MS. The findings indicated that ABILHAND, a newly developed self-report 
measure, had only weak correlations with the established tests of upper limb function, 
the NHPT and GPT. The publication of this finding would be useful for several 
stakeholders including original developers and the broader community interested in 
outcome measures for upper limb function. Providing feedback for developers might 
lead to amendments or lead to recommendations that the outcome measure is not 
suitable for the MS population. Alternatively, the result forms part of evidence-based 
practice for upper limb function assessment in MS, which benefits other researchers 
in the field in the selection of appropriate outcome measures. 
Numerous organisations such as MS Trust have recommended the study of cognition 
in MS as a priority as often it is a ‘hidden’ problem that contributes to the clinical 
situation. Moreover, NICE (2014) guidelines explicitly recommend research focusing 
on cognition. The present study offers insight into cognitive difficulties experienced 
by individuals with MS and therefore aligns with policy goals. Moreover, by ‘revealing’ 
cognitive difficulties associated with MS, there is the hope that it has a beneficial 
impact for all those affected by the disease. This might take form at an individual level 
by increasing awareness of cognitive symptoms or at an organisation level such as an 
employer making reasonable adjustments in the workplace to accommodate cognitive 
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changes. By the virtue of conducting research within the area, the research has the 
potential to have a beneficial impact in many spheres, therefore it is important to 
consider how to achieve this impact (see Dissemination). 
Finally, meeting people with MS over the thesis has also had a personal impact. It was 
a privilege to conduct research with such a welcoming group and I thoroughly enjoyed 
all the offers of tea, coffee and cake. I was struck at how many people were willing to 
make the time to participate in research and to hear the reasons for doing so. My 
impression is that there was a sense of cohesion in the shared experience of MS and 
people felt strongly about ‘doing their bit’ for future generations. The experience has 
taught me about the real-world challenges of living with MS but also how it is possible 
to live a rich and meaningful life. I saw the value of having a supportive network 
around a person in terms of family, friends and accessible services. As a result, I am in 
a stronger position going forward in terms of my insight into the challenges facing 
those living with a chronic condition and knowledge of resources which should aid in 
my future career aspirations in neuropsychology. 
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4.3 Dissemination 
For the research to reach a diverse audience, the dissemination strategy focuses on a 
communication campaign across several channels, including social media and more 
traditional routes such as relevant journals to communicate the research. The main 
aim is to make the research widely available to encourage engagement and promote 
participation in research of cognition in MS.  
The initial dissemination strategy includes a plain English summary of the research to 
the participants who indicated they would like to receive a summary of findings on the 
consent form. This process involves consultation with the other research collaborators 
to produce an agreed version before sharing with participants. Many participants 
expressed an interest in the outcome of the research, given their involvement in the 
study over the last 12 months, so this is an important part of the strategy. 
Following a conversation with a study participant, it was agreed that a short oral 
presentation at a local MS peer-led group attached to a neurology clinic may be 
another opportunity to share the findings of this research. This would enable us to 
reach an audience beyond those involved in the study and an interactive session to 
ask specific questions and open conversations about the implications of the results. 
This could encourage wider participation in research and lead to further opportunities 
to communicate the research further afield. 
A separate version of the research summary will be produced for the clinical teams at 
both participant identification sites. The process will be similar to the above, all 
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collaborators will be invited to share thoughts on an initial draft before an agreed 
version is shared. This summary is tailored to clinicians rather than participants, so 
there may be some subtle differences. 
A key part of the dissemination strategy is the submission of an abstract for the 
ECTRIMS 2018 conference in Berlin. The European Committee for treatment and 
research in Multiple Sclerosis (ECTRIMS) is the world’s largest scientific meeting 
dedicated to the understanding and treatment of MS. It offers an opportunity to 
disseminate research through an annual international conference. If the abstract is 
accepted, it would provide an excellent means of maximising the findings of the 
research to a targeted global audience. In addition, the research would be stored on 
an online library so that others can access the research abstract after the conference 
and published in the Multiple Sclerosis Journal Online. Furthermore, there is an 
opportunity for an oral poster presentation if deemed ‘outstanding’ by the 
committee. 
Beyond the immediate participants and recruitment sites, dissemination to a wider 
audience involves communication with larger relevant organisations and popular 
online MS or medical blogs, as well as more traditional publication routes. Some key 
priorities include: 
- The MS Trust offers numerous channels to market and publicise recent 
research, such as Open Door, a free quarterly newsletter for people with MS 
and applying to present a poster at the next MS Trust Conference in September 
2018. 
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- The Barts and The London Neuroimmunology Group’s BartsMS Blog - 
http://multiple-sclerosis-research.blogspot.com, has also been identified as a 
useful blog to contact as they have behind several successful social media 
campaigns (e.g. #ThinkHand) and remain a consistent source of information 
for MS research. This blog has a special interest in the use of upper limb 
function in MS and given the relevance of our outcome measures, it is 
anticipated that the blog would be interested in learning more about the study. 
An element of flexibility in the method of disseminate the findings would be 
needed for larger organisations (e.g. short, snappy headline with links to a 
fuller description).  
- Multiple Sclerosis and Related Disorders (MSARD) journal has been identified 
as suitable for approaching for publication of the systematic review and this 
would enable a reach to a more traditional audience in academia. The journal 
has a special interest in MS neuropsychology and measurement scales with 
options for open access.  
- Multiple Sclerosis Journal (MSJ) has been considered suitable for publication 
of the empirical study. A shorter version of the thesis would be prepared with 
other collaborators and a manuscript sent for review. If unsuccessful, 
alternative journals will be considered. 
Social media is a valuable marketing communication tool to help promote the research 
to a much wider audience to encourage engagement and interest. Throughout the 
duration of this thesis, I have used my social media account on a periodic basis to raise 
the profile of the research, identifying key findings and points of discussion and using 
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hashtags contributing to other relevant conversations to gain further visibility and 
followers. Post-thesis submission, part of the dissemination strategy includes 
producing a YouTube video with a short 2-minute video with a summary of the 
research and then posting this on Twitter/ YouTube and various blogs to generate 
further engagement. In addition, the strategy includes weekly tweets on Twitter for 6 
- 8 weeks post-thesis around key themes in the research and timed around major 
events to provoke further conversations related to the research, share future 
developments (e.g. ECTRIMS abstract acceptance) and provide links to some of the 
materials mentioned above.  
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Appendix 23: Skewness and Kurtosis Calculations Baseline Data 
 
RR-MSc RR-MSnc HC  
Skew Kurtosis Skew Kurtosis Skew Kurtosis 
BVMT-R -0.28 -1.21 -1.86 -0.31 0.92 -0.83 
CVLT-II -0.65 -0.70 0.22 -0.76 0.16 -0.98 
FSS -1.28 -0.49 -1.20 -0.76 0.12 -0.22 
GPT 2.54 1.42 2.33 0.95 0.40 0.90 
HADS A 0.74 -0.29 0.75 -0.83 2.56 1.62 
HADS D -0.05 -1.03 0.80 -0.82 0.32 1.18 
MPI 2.52 1.43 2.90* 1.54 0.46 -0.66 
NHPT 0.86 -0.96 0.22 -0.88 -0.88 -0.73 
PASAT-3 0.62 -0.94 -1.47 -0.25 0.11 -0.98 
SDMT -0.63 -0.81 -0.93 1.19 2.03 1.20 
TOPF 1.24 1.40 -0.24 0.38 0.22 -0.83 
WLG -0.56 -0.93 -0.22 -0.77 -1.26 1.28 
Scores < ±2.58 meet criteria for normal distribution (p < .01). * Scores > ±2.58 (must be 
transformed) 
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Appendix 24: Skewness and Kurtosis Calculations Follow-up Data 
 
RR-MSc 
 
RR-MSnc 
 
HC 
 
 
Skew Kurtosis Skew Kurtosis Skew Kurtosis 
ABILHAND -0.41 -1.13 -2.75* 1.18 -2.26 0.72 
BVMT-R -0.70 -1.07 -2.47 1.09 -0.24 -0.75 
CVLT-II -0.45 0.41 -1.10 -0.85 0.04 0.32 
FSS -0.76 -0.93 0.09 -0.82 -0.29 -1.06 
GPT 2.08 1.11 0.66 -0.69 0.49 -0.58 
HADS A 1.08 -0.65 0.73 -0.45 0.76 0.96 
HADS D 0.00 -0.94 -0.60 -0.65 1.17 0.70 
MPI 1.96 0.89 0.74 -0.22 0.06 -1.07 
NHPT 3.13* 2.05 2.53 1.37 -0.02 -1.16 
PASAT-3 -0.67 -0.88 -1.99 0.76 0.43 -0.88 
SDMT -0.90 -0.44 -0.88 0.79 0.96 -0.95 
TOPF 0.09 -0.62 0.31 -1.04 0.27 -0.63 
WLG 0.26 -0.92 0.23 -0.62 0.18 -0.91 
Scores < ±2.58 meet criteria for normal distribution (p < .01). * Scores > ±2.58 (must be 
transformed) 
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Appendix 25: Skewness and Kurtosis Transformations 
Variable  RR-MSc RR-MSnc HC 
Transformation Skew Kurtosis Skew Kurtosis Skew Kurtosis 
ABILHAND 
Square 
Root 
0.06 -1.16 1.49 -0.21 2.26 0.72 
MPI 
Baseline 
Log 10 1.49 0.48 1.83 0.80 0.30 -0.65 
MPI FU Log 10 0.50 0.50 -0.28 0.21 -0.02 -1.06 
NHPT 
Baseline 
Log 10 0.58 -0.99 -0.05 -0.96 -1.01 -0.64 
NHPT FU Log 10 2.13 1.51 1.74 0.95 -0.04 -1.14 
Scores < ±2.58 meet criteria for normal distribution (p < .01). 
 
 
